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ABSTRACT 
 
An On-Target Performic Acid Oxidation Method Suitable for Disulfide Bond 
Elucidation Using Capillary Electrophoresis - Mass Spectrometry. (May 2010) 
Brad Jay Williams, B.S., Southeastern Oklahoma State University 
Chair of Advisory Committee: Dr. David H. Russell  
 
 Disulfide bonds play important roles in establishing and stabilizing three-
dimensional protein structure, and mass spectrometry (MS) has become the primary 
detection method to decipher their biological and pathological roles. Several 
experimental methods before or after MS detection have been developed to aid in 
disulfide bond assignment, such as tandem MS followed by database searching or 
modification of the disulfide bond via chemical reduction or oxidation. Despite these 
technological advancements, the detection and proper assignment of disulfide bonds 
have remained experimentally difficult. Therefore, we have developed an alternative 
method for disulfide bond elucidation using capillary electrophoresis – mass 
spectrometry (CE-MS) combined with an on-target performic acid oxidation method for 
matrix assisted laser desorption/ionization (MALDI) deposited samples. 
  An information rich CE-MS method that results in distinct charge-state trends 
observed in two-dimensional plots of log(µeff) versus log (MW) was developed to 
enhance the confidence of peptide and protein identifications. The charge-state trends 
provide information about the number of basic amino acid residues present within each 
  iv  
peptide. This information can be used to develop methods to screen for post-
translationally modified peptides (e.g., phosphorylation, disulfide bonds, etc.). In the 
case of disulfide bonds, the highly charged peptides (i.e., +3, +4 or greater charge states) 
have a high probability of being disulfide-linked peptides, owing to charge contribution 
of both peptides forming the disulfide bridged peptide. However, intra-linked disulfide 
bridged peptides can also be present at lower charge states. Therefore, a chemically 
selective method to rapidly locate disulfide-linked peptides that have been separated by 
CE-MS must be developed. 
An on-target performic acid oxidation method was developed to provide the 
chemical selectivity towards disulfide bonds, i.e., converting the cystine bond to form 
two peptides modified with a cysteic acid (SO3H) side chain. The on-target oxidation 
method offers (i) no post-oxidation sample cleanup, (ii) improved throughput over 
solution-phase oxidation methods, and (iii) easily adapted to CE separations coupled off-
line with MALDI-MS. The evaluation of the on-target oxidation experimental 
parameters, the fragmentation behavior of cysteic acid-containing peptides and an 
alternative method for disulfide bond elucidation, using CE-MS combined with the on-
target oxidation method, are discussed within. 
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CHAPTER I 
INTRODUCTION 
 
Improvements in the fields of separation science, mass spectrometry (MS) and 
bioinformatics have been required to gain insight into the proteome and cellular 
processes of various microorganisms. Traditional proteome level protein separations are 
carried out using two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) 
utilizing isoelectric focusing as the first dimension separation followed by a size-based 
separation in the second dimension.1-4 After appropriate protein staining the protein 
spots are excised and subjected to in-gel proteolytic digestion, which can be quite 
laborious and mid-to-low throughput. The in-gel digestions are then analyzed by either 
electrospray ionization (ESI) or matrix-assisted laser desorption/ionization (MALDI) – 
MS followed by database searching and peptide mass mapping for protein 
identification.5-8 Even today, 2D-PAGE still remains a workhorse in the proteomics field 
owing to the high resolving power of the two-dimensional separation. 
Several liquid-phase separation techniques (e.g., high-performance liquid 
chromatography (HPLC) or capillary electrophoresis (CE)) have proven useful to 
increase dynamic range, reduce sample complexity, and increase the confidence level of 
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peptide identification for “bottom-up” proteomics.9-11 In the traditional bottom-up 
proteomics experiment, intact proteins are first subjected to proteolytic digestion using 
trypsin (cleaves C-terminally to lysine and arginine residues, except when followed by 
proline) followed by pre-fractionation prior to MS analysis and subsequent peptide mass 
mapping. As a brute force approach, multi-dimensional separation schemes using strong 
cation exchange chromatography (SCX) combined with reverse phase liquid 
chromatography (RPLC) and ESI-MS have been developed as an alternative to 2D-
PAGE. For example, Yates and coworkers developed the multidimensional protein 
identification technology (MudPIT) in which they successfully identified ca. 1500 yeast 
proteins.12 As opposed to increasing the number of separation dimensions, some research 
groups have increased the information content by incorporating LC retention time into 
their proteomic study to increase specificity, throughput, and proteome coverage.13-18 
The LC retention time combined with high mass measurement accuracy (i.e., ~ 1 ppm) 
can be used to streamline LC-MS proteomic analyses to nearly eliminate the need for 
tandem MS to identify proteins.13 
On the other hand, CE offers certain advantages over LC including increased 
separation efficiency and an alternative separation mechanism based on the peptide 
hydrodynamic size-to-charge ratio. Several successful proteomic studies have employed 
CE-MS for protein identification9, 19 and biomarker discovery from urine polypeptides.20-
24 CE-MS also provides a migration time which is inherent of the peptide’s size-to-
charge ratio. For example, Wittke and coworkers23 presented data on urine polypeptides 
using CE-MS in which 2D plots of m/z versus migration time yield visible trends, 
  3  
although at the time an explanation of their origin was not given. Similar trends can also 
be seen in CE-MS data taken from similar studies of Kaiser, et al.20, 21 and Theodorescu, 
et al.22 The distinct trends observed in CE-MS plots of log(µeff) versus log (MW) were 
determined to be related to the peptide charge state which gives an indication of the 
number of basic amino acid residues present within the peptide.19 This additional 
information adds analytical utility towards improving the confidence of protein 
identification and provides means for detecting charge state altering modifications (e.g., 
phosphorylation, cysteine oxidation, etc.) within complex mixtures. Hence, the main 
goal of the work presented within is to utilize the information provided in the 2D CE-MS 
plots to simplify the detection of post-translationally modified peptides, such as 
phosphorylation, cysteine oxidation, and disulfide bonds. 
Even though CE-MS provides high separation efficiency, low sample 
consumption, and the distinct charge state trends; there is a significant disadvantage in 
the loading capacity of CE compared to LC. Typical CE capillaries have a total capillary 
volume of 1-2 µL allowing injection volumes in the nanoliter range. As a rule of thumb 
injections for CE are ≤1% of the total capillary length.25 This helps prevent concomitant 
band broadening associated with large injection volumes. As for LC, injection volumes 
are in the microliter range allowing more analyte to be injected.  Hence, the main 
difference between LC and CE is the concentration limit of detection, i.e., more 
concentrated samples are required for CE-MS. In an effort to enhance the loading 
capacity of CE, several sample stacking protocols (e.g., field-amplified sample 
stacking,26, 27 large volume sample stacking,28, 29 isotachophoresis,30, 31 etc.) have been 
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developed to mitigate this issue. The majority of the sample stacking protocols work on 
the basis of a high field strength created within the low conductivity sample zone. The 
low conductivity sample zone can be achieved by preparing the sample in pure water, 
mixed organic solvent with partial aqueous content (e.g., acetonitrile, ethanol, methanol) 
or a low conductivity buffer such as triethanolamine or 
tris(hydroxymethyl)aminomethane.32 Briefly, the sample stacking results from the low 
conductivity sample plug which causes a drastic increase in field strength and the 
positive ions rapidly stack as a narrow band at the sample plug / background electrolyte 
interface.27, 33 Once the positive ions reach the electrophoresis buffer they continue to 
migrate according to their size-to-charge ratio. Typical sample enrichment factors range 
from 10-50 fold depending on the sample stacking technique and the sample 
composition.34 Overall, these relatively simple CE sample stacking protocols can 
improve the sensitivity to compare to those achieved by LC methods. 
The detection of post-translational modifications (e.g., phosphorylation, cysteine 
oxidation, and disulfide bonds) has become important to understand protein and cellular 
functions. For example, cysteine oxidation away from the active site of a protein kinase 
can result in disulfide bond formation with a nearby cysteine residue, which changes the 
protein conformation and enzymatic activity.35 Lately, several research groups have 
focused their attention towards studying the variable states of cysteine oxidation and 
their biological and pathological roles.36-39 The most commonly known states of cysteine 
oxidation are the thiol (RSH) and disulfide bond (R-S-S-R), but several cysteine 
oxoforms including sulfenic (RSOH), sulfinic (RSO2H), and sulfonic (RSO3H) acid are 
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being observed in an increasing number of proteins.40 Figure 1 contains the chemical 
structures of these cysteine oxidation states including the intermediates of disulfide bond 
oxidation. When disulfide bonds are exposed to a chemical oxidant (e.g., performic acid 
or hydrogen peroxide) several oxygen atoms are incorporated into the different cysteine 
oxoforms until the final product becomes a sulfonic acid. Sulfenic acids are known to 
have short lifetimes before additional oxidation occurs to produce disulfide bonds or 
sulfinic/sulfonic acids. Technologies to capture sulfenic acids using dimedone (i.e., 5,5-
dimethyl-1,3-cyclohexadimone) chemistry followed by antibody recognition and MS 
have been reported.36-38, 41, 42 Over thirty protein crystal structure have been reported to 
contain sulfenic acid modifications.43 The detection of the final cysteine oxidation 
product, sulfonic acid is rather straightforward since the oxidation is irreversible and 
MS-based detection schemes have proven effective.44, 45-48 However, the detection and 
assignment of disulfide bonds within proteins remains an analytical challenge. 
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Figure 1. Various states of oxidation for post-translationally modified cysteine. The 
oxidation number of the sulfur atom in each cysteine oxoform is shown. This figure was 
adapted from Reddie and Carroll.40 
 
Disulfide bonds are particularly important to stabilize and maintain native protein 
structures,49, 50 and MS has played an increasingly important role in deciphering these 
processes,51 especially protein folding/unfolding kinetics.52-54 The basic experimental 
scheme for assigning disulfide bond involves: (i) proteolytic digestion of the non-
reduced protein into disulfide-linked peptides with cleavage between all half-cystine 
residues, (ii) separation of the disulfide-linked peptides; (iii) locate and identify the 
disulfide-linked peptides in each fraction; (iv) cleave the disulfide-linked peptides at the 
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disulfide bond to leave the half-cystinyl products to be further characterized. 51 This 
basic strategy to identify disulfide bonds has been modified with the development of 
advanced separation science and MS methodologies, but overall the experimental 
scheme remains similar. For example, Morris and Pucci developed a method to compare 
the mass spectra for the non-reduced and reduced proteolytic digest of bovine insulin.55 
The different disulfide bond arrangements were proposed based on the observed half-
cystinyl peptides. The comparison of non-reduced versus reduced proteolytic digests of 
disulfide-containing proteins has become the classical approach to determine disulfide 
bond patterns within proteins. 
Prior to MS analysis, there are several experimental variables during proteolytic 
digestion of a disulfide-containing protein that are important to maintain the native 
disulfide bond pattern. For example, disulfide bonds can undergo nucleophilic cleavage 
under alkaline conditions (pH 8) and can readily react with a free thiol group to produce 
a scrambled/exchanged disulfide bond.51 Since the majority of the proteases (e.g., 
chymotrypsin, trypsin, endoproteinase AspN) used for MS-based proteomics are active 
at or near pH 8 this becomes an issue to maintain the native disulfide bond pattern. To 
overcome this issue, alternative proteases such as pepsin (C-terminal cleavage after Ala, 
Leu, Phe, Tyr, Trp) that are active at acidic conditions (pH 2-3) or digestion can be 
performed under mildly acidic (pH 6) conditions to minimize disulfide scrambling.56 
The temperature must be carefully controlled to minimize disulfide bond scrambling. 
For example, severe disulfide scrambling results (ca. 20 non-native disulfide-linked 
peptides) when thermal denaturation (90˚C) procedures are used to denature bovine 
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Ribonuclease A (RNase A) prior to proteolytic digestion. Another challenge during 
proteolytic digestion is the inaccessibility of the protease to cleave the protein in regions 
where the disulfide bonds are buried or not solvent exposed.53, 54 Dual enzyme digestion 
schemes (e.g., trypsin followed by chymotrypsin)56 or alternative proteases  (e.g., pepsin, 
Endoproteinase AspN, Endoproteinase LysC, etc.) could help improve the digestion 
efficiency. 
Several experimental approaches to assign disulfide bonds within proteins have 
been reported over the last thirty years.51 Particularly, several different MS-based 
methods including: tandem MS,57, 58 database search algorithms,56, 59-61 chemical 
reduction, 55, 62, 63 chemical oxidation, 46, 47, 64 metal ion cleavage of disulfide bonds, 65, 66 
and recently gas-phase scrambling of disulfide bonds during MALDI-MS.67 Many recent 
experimental schemes to determine disulfide bonds involve fragmentation of intact 
disulfide-linked peptides followed by database searching using a newly developed 
search algorithm. For example, Xu and coworkers developed a tandem MS search 
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engine to simplify database searches of fragment ion spectra of intact disulfide-linked 
peptides.56 As illustrated in Figure 2, the fragment ions of an interlinked disulfide 
bridged peptide can be quite complicated. The accepted peptide fragmentation 
nomenclature68 has been modified for disulfide and/or cross-linked peptides,57 i.e., 
fragmentation on the α-chain would be denoted as αyn or αbn for cleavage of the peptide 
bond with charge retention at the C- or N-terminus, respectively. Further fragmentation 
nomenclature including side-chain loss fragment ions will be discussed in more detail in 
Chapter V. The majority of interlinked disulfide-containing peptides primarily fragment 
at the disulfide bond to produce the signature fragment ions for a disulfide bond (See 
Figure 2 inset). A limited number of sequence-informative fragment ions can result from 
each α- and β-chain peptide forming the disulfide linkage depending of their amino acid 
composition.57 Therefore, every single disulfide-linked peptide cannot be assigned via 
tandem MS alone, additional chemical modifications or other methodologies could be 
needed to further assist in the disulfide bond assignment. 
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Figure 2. Fragmentation nomenclature for an inter-linked disulfide bridged peptide with 
generic side chains. Inset figure: the signature disulfide bond fragment ions resulting 
from gas-phase cleavage of the disulfide bond are also shown. The fragment ions 
resulting from cleavage of the -S-S- bond between the two sulfur atoms are shown 
(bottom left).57 
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Through chemical reduction or oxidation the disulfide bond can be chemically 
cleaved to produce two peptides with either the free thiol (RSH) form or the cysteic acid 
(RSO3H) form. As a modification of the traditional Morris and Pucci 55 approach using 
chemical reduction to assign disulfide bonds, a reductive MALDI matrix, 1,5-
diaminonapthalene (1,5-DAN) has been used to reduce the disulfide bond during the 
MALDI process.62, 63 For example, Quinton and coworkers used 1,5-DAN as the 
MALDI matrix to characterize disulfide-linked peptides using LC coupled off-line with 
MALDI-MS/MS.63 The reductive MALDI matrix reduces disulfide bonds during the 
MALDI event; however, 1,5-DAN yields a high relative abundance of matrix clusters up 
to 1000 m/z, which prevents the analysis of low molecular weight disulfide and/or 
cysteine-containing peptides. Disulfide bonds can also be cleaved during the MALDI 
process without the use of a reductive MALDI matrix. For example, Schnaible et al. 
developed a screening method for disulfide bonds based on LC pre-fractionation 
combined with post-source decay of the disulfide bond during the MALDI process to 
produce two peptide chains that form the inter-linked disulfide bond.58 The disulfide 
bonds from bovine serum albumin and bovine RNase A can be elucidated by back-
calculating the intact disulfide-linked peptide masses. Using this approach, the free 
cysteine-containing peptides become difficult to distinguish from those that are formed 
from gas-phase cleavage of the disulfide bond as a result of post-source decay. 
Therefore, an approach such as chemical oxidation that can simultaneously cleave and 
chemically modify the sulfur atoms involved in the disulfide bond would be beneficial. 
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 Compared to chemical reduction of the disulfide bond, chemical oxidation offers 
the following benefits: (i) a 48 Da mass shift occurs per cysteine residue, (ii) cysteic acid 
(SO3H) enhances negative ion formation, and (iii) the chemical oxidant simultaneously 
cleaves the disulfide bond and chemically modifies each peptide involved in the 
disulfide bridge. Chemical oxidation can be achieved using either performic acid 46, 47, 64, 
69} or hydrogen peroxide.37, 70 Performic acid under controlled conditions selectively 
oxidizes cystine, cysteine, and methionine amino acid residues. In the case of disulfide 
bonds, the sulfur – sulfur bond is broken to form two peptides, each modified with a 
cysteic acid (See Figure 1). As for methionine, up to two oxygen atoms can be 
incorporated to produce the sulfone form (RSO2CH3). Sun and Smith reported the first 
approach using performic acid oxidation combined with MS for disulfide bond 
determination.46 Solution-phase oxidation was used to successfully oxidize standard 
peptides and proteolytic digests of bovine insulin and RNase A. Using this approach 
they were able to elucidate two disulfide bonds of bovine insulin. Despite their success, 
the experimental protocol for solution-phase performic acid oxidation is quite laborious 
and low-to-mid throughput.  
Traditional solution-phase oxidation methods are performed on lyophilized 
peptide/protein samples using reaction times ranging from 2-4 hrs 47, 71, 72 and several 
steps are required after oxidation to remove the performic acid reagent prior to MS 
analysis. Solution-phase oxidation methods with decreased reaction times (10-30 min) 
have been reported for the oxidation of cysteine/methionine containing peptides; 
however, the additional clean-up steps after oxidation make this method less desirable.46 
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In an effort to decrease reaction time and the steps prior to MS analysis, on-target 
oxidation methods using solution-phase performic acid have also been successfully 
applied to MALDI spots containing peptides and/or proteolytic digests.71 For example, 
we showed that directly adding the performic acid solution to a pre-spotted MALDI 
deposit containing a bovine apo-transferrin tryptic digest yields oxidized tryptic 
peptides; however, the signal-to-noise (S/N) ratios of the oxidized peptide negative ions 
decreased by 5-fold because of ion suppression effects. The overall amino acid sequence 
coverage also decreased by half compared to the solution-phase oxidized sample. Thus, 
an on-target performic acid oxidation method that can mitigate these adverse effects 
would be highly beneficial. The ideal on-target oxidation method would offer the 
following characteristics over solution-phase oxidation methods: (i) simple experimental 
procedure with no post-oxidation sample cleanup; (ii) decreased ion suppression effects 
following oxidation; (iii) improved throughput over solution-phase methods; and (iv) 
maintain positive and negative ion mass spectral quality following on-target oxidation. 
Additionally, an on-target oxidation method that can simultaneously oxidize entire CE or 
LC-MALDI separations which would certainly be beneficial to develop screening 
methods to locate disulfide bonds within complex mixtures. 
Herein we describe an alternative method for disulfide bond elucidation using 
on-target oxidation combined with CE-MS. The 2D CE-MS plots of log(µeff) versus log 
(MW) provide additional information (charge state or number of basic amino acid 
residues) which improves the confidence of peptide and protein identifications. Owing to 
the high charge state (i.e., +3, +4 or greater) of an intact disulfide-linked peptide, these 
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2D CE-MS plots can be used to develop a screening method for disulfide-linked 
peptides. The entire CE-MS separation can be subjected to on-target oxidation which 
provides chemical selectivity towards oxidizing the intact disulfide-linked peptides. 
Presented within is the (i) development of CE-MS methods resulting in distinct charge 
state trends, (ii) introduction of a high-throughput on-target oxidation method, (iii) 
evaluation of the on-target oxidation experimental parameters, (iv) investigation of the 
effect of the cysteic acid position on the negative ion fragmentation of oxidized cysteine-
containing peptides, and (v) the combination of the on-target oxidation method with CE-
MS separations as an alternative method for disulfide bond elucidation.  
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CHAPTER II 
UTILITY OF CE-MS DATA IN PROTEIN IDENTIFICATION* 
 
Introduction 
The task of identifying and quantifying the proteome is daunting and has 
required continued improvements in separation science, mass spectrometry (MS), and 
bioinformatics. A great deal of progress has been made in studies of protein expression 
by using 2D gel electrophoresis to separate/isolate individual proteins, which are then 
identified by MS methods such as peptide mass mapping and peptide sequencing.1-4 The 
low throughput nature of these experiments led to the development of bottom-up MS and 
top-down MS techniques, as well as multidimensional separations (LC-MS and LC-
MS/MS) strategies for the identification of proteins within complex mixtures,12, 73, 74 and 
the characterization of protein complexes and microorganisms.75-77 The combination of 
liquid-phase separation techniques, i.e., high-performance liquid chromatography (LC), 
with MS increase dynamic range, reduce sample complexity, and increase confidence 
level of peptide identification.9-11 Two-dimensional (2D) LC-MS methods are also 
frequently used.12, 78 Although 2D separation increases the depth the proteome can be 
analyzed, there is a concomitant increase in the analysis time. In an effort to enhance 
proteomic analysis to include the complete proteome, several groups have added even 
 
__________________ 
* Reproduced with permission from Williams, B.J.; Russell, W.K.; Russell, D.H. Utility 
of CE-MS Data in Protein Identification. Anal. Chem. 2007, 79, 3850-3855. Copyright 
2007 American Chemical Society. (APPENDIX A) 
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more separation dimensions, whereas other groups have attempted to increase the 
information content of the current analysis by incorporating LC retention time into 
proteomic studies to increase specificity, throughput, and proteome coverage.13-18 
The majority of LC-MS proteomic studies are based on electrospray ionization 
mass spectrometry (ESI-MS);79, 80 however, coupling separations with matrix-assisted 
laser desorption/ionization mass spectrometry (MALDI-MS) offers numerous 
advantages and is becoming more commonplace.81-85 MALDI yields almost exclusively 
singly-charged ions resulting in less spectral congestion, and an increase in sensitivity, 
due to all ion current being in one ion species.  MALDI also has a relatively higher 
tolerance of salts, and the ability to archive samples for later study. 
An advantage of capillary electrophoresis (CE) over HPLC based separations is 
the increased separation efficiency. There are several studies which have utilized CE-MS 
to analyze complex mixtures of peptides with great success.20-24, 86 CE-MS also provides 
a migration time for each peptide and perhaps additional information.  Wittke and 
coworkers23 presented data on urine peptides analyzed using CE-MS.  Plots of m/z 
versus migration time yielded visible trends in the data, although an explanation of their 
origin was not given. Similar trends are also seen in CE-MS data taken from the studies 
of Kaiser, et al.20, 21 and Theodorescu, et al.22 The goal of our work is to utilize the 
information provided in these 2D plots of m/z versus CE migration time to determine 
specific applications where CE-MALDI-MS can be employed as a tool to aid in 
peptide/protein identification.   
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This report describes a CE-MALDI-MS method that results in distinct trends 
observed in plots of m/z versus CE migration time from proteolytic digests. To explore 
the origin of these trends, we use two sets of lysine-containing peptides to validate the 
charge state of α-casein proteolytic peptides along each trend. In addition, a peptide 
electromigration model for peptides is used to validate this charge state trend 
observation to ensure our CE-MALDI-MS data behave according to theory.87 Potential 
applications where these charge-specific trends exhibit analytical utility for more 
confident peptide identifications and to aid in post-translational modification (PTM) 
detection are discussed. 
 
Experimental 
Chemicals and Sample Digestion Procedures 
Bradykinin (2-9) (PPGFSPFR), adrenocorticotropic hormone (ACTH) (18-39) 
(RPVKVYPNGAENESAEAFPLEF), bovine α-casein, α-cyano-4-hydroxycinnamic acid 
(CHCA), dihydrogen ammonium phosphate (AP), and ammonium bicarbonate (ABC) 
were purchased from Sigma (St. Louis, MO). Ac-(AAKAA)nY-NH2 (n = 3-7) and Ac-
Y(AEAAKA)nF-NH2 (n = 2-5) peptides were purchased from Genscript Corporation 
(Piscataway, NJ). Mass spectrometry grade trypsin was purchased from Promega 
(Madison, WI). HPLC grade methanol (MeOH) and isopropanol (IPA) were purchased 
from EMD Chemicals Inc. (Gibbstown, NJ). All experiments were performed with 18-
MΩ water (ddH20) purified using a water purification unit (Barnstead International, 
Dubuque, IA). CHCA was recrystallized prior to use. All other chemicals were used as 
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received. A modified procedure from Park and Russell88 was used to perform proteolytic 
digestion. Briefly, α-casein was prepared at 1 mg mL-1 concentration in 50-mM aqueous 
ABC. A 100-µL aliquot of the protein solution was thermally denatured by incubating at 
90˚C for 15 min and subsequently quenched in a -20˚C freezer. The protein samples 
were digested overnight at 37˚C using trypsin (20 µg mL-1) prepared in 50-mM acetic 
acid. The Escherichia coli (E. coli) lysate sample was first separated using LC into 16 
fractions and subsequent fractions were digested with trypsin. A single digested fraction 
was used for CE-MALDI-MS analysis shown here. 
 
MALDI Matrix Preparation for CE-MALDI-MS 
A layer of 5-mg mL-1 CHCA was applied prior to the CE separations using an x-
y-z translation stage (ProBot™, LC Packings, Sunnyvale, CA). CHCA was dissolved in 
12:7:1 MeOH:ddH20:IPA with 10-mM AP and doped with 50-fmol µL-1 bradykinin 
fragment 2-9 and 150-fmol µL-1 ACTH fragment 18-39 as internal calibrants. AP was 
added according to a modified matrix preparation procedure by Smirnov and 
coworkers.89 The matrix solution was infused through a fused-silica capillary at 1.0 µL 
min-1 with a 5 second spotting interval to prepare a 30 row by 30 column array (900 total 
spots). MALDI plates were used for CE fraction collection using the sheath liquid 
mentioned in the CE-MALDI section as an overlayer.90, 91 
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Sample Preparation for CE-MALDI-MS 
Ac-(AAKAA)nY-NH2 (n = 3-7) and Ac-Y(AEAAKA)nF-NH2 (n = 2-5) peptides 
were prepared at 5 mg mL-1 in ddH20 and diluted 10-fold in 250-mM formic acid (FA) 
5-mM AP for CE-MALDI-MS analysis. These charge-state marker peptides were spiked 
into the α-casein digest (1 mg mL-1) at a concentration of 0.5 mg mL-1. The E. coli lysate 
fraction digest was prepared using a sample stacking protocol, field-amplified sample 
stacking (FASS),33 to improve the loading capacity of CE. Briefly, a 15 µL aliquot of the 
digested E. coli lysate fraction was lyophilized and resuspended in 5 µL of a 66% MeOH 
solution containing 85-mM FA and 1.7-mM AP then vortexed for 30 seconds. 
CE-MALDI 
CE separations were carried out on a 70-cm (50 µm i.d., 360 µm o.d.) fused-
silica capillary (Polymicro Technologies, Phoenix, AZ) with 200-nm UV detection at 50 
cm on a homebuilt apparatus equipped with pressurized rinsing and timed injections. 
The cathodic capillary tip was uniformly tapered using a rotary polishing tool (Dremel, 
Racine, WI) and interfaced to the ProBot as previously described by Johnson and 
coworkers.83 Sheath liquid composed of 50% MeOH, 125 mM FA, and 2.5 mM AP was 
applied at the cathodic end of the capillary at 500 nL min-1. The background electrolyte 
consisted of 250-mM FA and 5-mM AP at pH 2.20. Pressurized injections were 
performed at 1.0 psi and 2.0 psi for 6 and 30 seconds, respectively. These injections 
correspond to 10 nL and 100 nL as estimated by CE Expert™ software (Beckman 
Coulter, Fullerton, CA). The experiments with the charge-state marker peptides and α-
casein were performed using 10-nL injections with a 10-second spotting interval 
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between fractions. The E. coli lysate fraction CE-MALDI-MS experiments were 
performed using 100-nL injections and a 5-second spotting interval. CE separations were 
performed at a potential of +25 kV, using a 30-kV high-voltage power supply (Gamma 
High-Voltage Research, Ormond Beach, FL). UV electropherograms were collected 
using a homebuilt virtual instrument interface in the LabView 7.1 (National Instruments, 
Austin, TX) environment. 
 
MALDI-MS and MALDI-MS/MS 
All MALDI-MS experiments were performed using a 4700 Proteomics Analyzer 
MALDI-TOF/TOF (Applied Biosystems, Foster City, CA). The MS data for the CE-
MALDI plates were acquired using the reflectron detector in positive mode (700-4500 
Da, 1900 Da focus mass) using 800 laser shots (40 shots per sub-spectrum) with internal 
calibration. Tandem MS data were acquired using the following precursor threshold 
criteria: S/N 40, 5 precursors/fraction, 150 ppm fraction-to-fraction precursor mass 
tolerance, chromatographic peak width 2 fractions, and 3600 laser shots (36 shots/sub-
spectrum). Collision induced dissociation tandem MS spectra were acquired using 10-
20% greater laser power than the MS spectra acquisition using air at the medium 
pressure setting as the collision gas with 1 kV of collision energy. All MS and MS/MS 
data were searched against the Swiss-Prot protein sequence database using the GPS 
Explorer (Applied Biosystems) software. The database search parameters used for 
Mascot92 (Matrix Science, London, UK) were the following: precursor mass tolerance: 
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50 ppm, taxonomy: mammalia, enzyme: trypsin, missed cleavages: 2, and variable 
modifications: oxidation (M) and phosphorylation (ST). 
 
Results and Discussion 
Figure 3 contains a plot of a proteolytic digest of an E. coli lysate, which 
illustrates the trends typically observed in plots of m/z versus CE migration time for our 
work and others.20-24, 86 There are roughly 400 unique peptides that appear to separate 
into at least four distinct trends.  The slope of each trend relative to each other decreases 
at longer migration times.  The observation of these trends in our CE-MALDI-MS data 
lead us to explore the relationship between the physicochemical properties of peptides, 
their migration times, and find if this information can be exploited to aid in the analysis 
of peptides. 
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Figure 3.  Plot of m/z versus CE migration time for an E. coli lysate fraction digest 
illustrating the observed trends in CE-MALDI-MS data. The peptides denoted as A and 
B correspond to ADLNVPVKDGK (m/z 1155.626) and ASLPTIELALK (m/z 
1155.698), respectively. The inset figures correspond to the MALDI-MS data for these 
two E. coli derived peptides. 
 
Several models have been developed that relate the electrophoretic mobility to 
the charge and peptide size.87, 93-98 For example, the Offord model states that the 
effective electrophoretic mobility (µeff) of a peptide is proportional to the charge-to-size 
ratio of the hydrated ion (q/MW2/3), where q is the charge and MW2/3 is an expression of 
the hydrodynamic size (Equation 1).87 
       3/2MW
qeff ∝µ                                             (1) 
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Further derivation of Equation 1 reveals that the CE migration time (tm) is directly 
proportional to the size-to-charge ratio (MW2/3/q) (Equation 2). 
                                                            
q
MWtm
3/2
∝                                              (2) 
Based on Equation 2, the peptide charge can be deduced from CE migration times and 
measured mass-to-charge (m/z) values.  The coefficient on the MW term in Equation 2 
can be experimentally derived from a plot of log (µeff) versus log (MW) to yield 
Equation 3:  
)log()log()log( kqMWsu eff +−=     (3) 
Where the s-term is the MW coefficient and k is a constant. The experimentally 
derived expression can be exploited to predict migration times of peptides, given the 
peptide molecular weight and charge. Kim and coworkers have also reported the use of 
an experimentally derived, semi-empirical model to correlate the µeff with a slightly 
different expression (q/MW0.56) for peptides resulting from proteolytic digestion of 
standard proteins.97 The relationship between the electromigration and physicochemical 
properties of peptides in CE separations can be illustrated by data obtained from two 
homologous series of lysine-containing peptide standards (Figure 4a). The 
corresponding UV electropherogram for this CE data is shown in Figure 4B to illustrate 
separation efficiency and short run times. These peptides, (AAKAA)nY and 
(AEAAKA)nF, are both acetylated at the N-terminus and amidated at the C-terminus. 
Effectively, these peptides function as in-solution charge state markers, the charge states 
of which correspond to the number of lysine residues within each peptide. For example, 
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the Ac-(AAKAA)4Y-NH2 peptide would exist in the +4 charge state at pH 2.2.  The 
charge state of peptides are determined using a charge-state calculator,99 which takes 
into account the acidic residues (Asp, Glu), the basic residues (Arg, His, Lys), the 
termini, and any charge altering modifications (N-terminal amidation, phosphorylation, 
etc.).  Since our experiment is performed at pH 2.2, the acidic residues do not influence 
the charge state of the peptide in solution.  The [M + H]+ ions for these standard peptides 
plotted against the measured CE migration time at the 70 cm elution point are shown in 
Figure 4a.  In both the (AAKAA)nY and (AEAAKA)nF series of peptides the higher 
molecular weight, highly charged species elute first, with the lowest charged peptides 
eluting at the longest time.  It is clear that peptides with similar mass but differing in 
charge state are easily separated, e.g., Ac-(AAKAA)3Y-NH2 with m/z = 1459.84 elutes 
ca. 4 minutes before Ac-Y(AEAAKA)2F-NH2 (m/z = 1452.75).  There also appears to be 
a correlation between peptides of the same charge-state, i.e., the standard peptides of 
identical charge state model the trends observed in Figure 3. 
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Figure 4. a.) Plot of m/z versus CE migration time for Ac-(AAKAA)nY-NH2 (n = 3-7, 
solid squares) and Ac-Y(AEAAKA)nF-NH2 (n = 2-5, solid triangles) standard peptides. 
b.) Corresponding UV electropherogram for the charge-state marker peptides, with 
migration times measured at the 50-cm detection point. 
 
Charge-based trends are most easily observed in Figure 5a, where peptides 
resulting from a digest of α-casein were spiked with the charge-state marker standard 
peptides and analyzed by CE-MALDI-MS. Figure 5a is plotted as the log (µeff) versus 
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log (m/z) to allow the experimental determination of MW coefficient (s-term) in 
Equation 3. Plotting the CE-MS data in this manner is important as µeff will correct for 
any inconsistencies in the experimental setup (e.g., potential, capillary length, capillary 
coating, etc.) between laboratories and experiments. Therefore, plotting CE-MS data this 
way becomes more useful in developing databases, since migration time can vary per 
experiment. The average coefficient of MW for all charge-based trends was 0.52 (R2 
value of 0.94), which is similar to the value of 0.56 obtained using an iterative analysis 
of experimental data by Kim and coworkers.97 This small inconsistency may be due to 
the relatively low number of peptides in our analysis and the scatter in the data.  The 
scatter should improve by using a coated capillary for the analysis, which is currently 
being investigated. The MW coefficient for each charge-based trend can be used to 
predict the migration time of an unknown peptide, given the potential peptide sequence 
and charge. Candidate peptides that fall along the proper charge-state trend are 
confirmed, whereas, those peptides that fall along the wrong trend are either post-
translationally modified or false positive identifications.  
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Figure 5. a.) Plot of log (µeff) versus log (m/z) for the α-casein proteolytic digest (closed 
diamonds) with the Ac-(AAKAA)nY-NH2 (n = 3-7, empty squares) and Ac-
Y(AEAAKA)nF-NH2 (n = 2-5, empty triangles) peptides added at 0.5 mg mL-1 each. b.) 
Table of α-casein peptides identified from each trend with their observed m/z values, 
mass error (ppm), calculated in-solution charge state (q), migration time (tm), effective 
electrophoretic mobility (µeff) and number of acidic/basic residues. Parenthetical 
numbers adjacent to each peptide sequence correspond to the Mascot MS/MS ion score.  
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The sequence of the α-casein derived peptides, and their corresponding charge 
states, were confirmed using accurate mass measurement and tandem MS.  Figure 5b 
contains the observed m/z for each peptide, mass error (ppm), calculated charge state 
(q), effective electrophoretic mobility (µeff), migration time (tm), and the number of 
acidic/basic residues for selected α-casein peptides that reside on each charge-state 
marked trend.  For example, we would expect the peptide HPIKHQGLPQEVLNENLLR 
(m/z 2235.24), denoted as A, to fall on the +5 trendline as it has four charge carrying 
residues plus the N-terminus charge. This is in agreement with the experimental data 
(Figure 5A).  Peptides denoted as B, G, and J in Figure 5b fall along the +4, +3, and +2 
charge-state trends, respectively, as we would predict based upon the number of basic 
amino acids.  An example mass spectrum is shown in Figure 6a for peptide G in Figure 
5a illustrating high mass spectral resolution (Rs ~ 16,500) and decreased mass spectral 
convolution. Figure 6b shows the tandem MS data for peptide G, demonstrating a 
sequence informative ion series of b and y-type fragment ions.  
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The vast majority of peptides are found on the +2 and +3 trend, indicating that 
the majority of peptides have zero or one missed cleavage. Since the peptides are all 
tryptic, all peptides should carry at least a +2 charge (Lys or Arg plus the N-terminus), 
except for a C-terminal peptide fragment and any peptide modified by a negatively-
charged group (e.g., phosphate or sulfonate) at the pH these experiments were performed 
(pH = 2.2).  Note that some peptides fall below the +2 trendline (See Figure 3a). For 
example, the peptide denoted as M should appear along the +2 trend, however this 
peptide is observed on the +1 peptide trendline.  Upon examination of the tandem MS 
data, it was found that this peptide (VPQLEIVPN(pS)AEER) contains a phosphorylation 
site, altering the peptide charge to the +1 state.  Effectively, using CE-MS to analyze 
proteolytic digests reduces the number of required analyses of phosphorylated peptides 
to those that lie on the +1 trend.  However, it is possible for phosphorylated peptides to 
fall on other trendlines. Such is the case for YKVPQLEIVPN(pS)AEER (m/z 1951.955), 
denoted as K, which contains a missed cleavage and falls on the +2 trendline.  Kim and 
coworkers also observed that peptides containing certain PTMs deviate from this linear 
correlation of µeff with q/MW0.56, owing to an incorrect calculation of the charge state for 
those peptides.97 
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Figure 6. a.) Mass spectrum of a CE fraction (12.17 min) from the separation of α-
casein proteolytic digest spiked with the charge-state marker peptides. Inset figure: 
expanded view of the peptide at 1759.94 m/z to illustrate the mass spectral resolution of 
~ 16,500 measured at FWHM. b.) Tandem mass spectrum of the ion signal at 1759.94 
m/z corresponds to HQGLPQEVLNENLLR from CASA1_BOVIN with a Mascot 
MS/MS ion score of 103. 
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Utility of Charge-State Specific Trends for Protein Identification 
The CE-MS charge-based trends observed provide complementary information 
to proteomic analysis similar to AMT tags from LC-MS analysis.13, 14, 16 However, the 
CE-MS data provides much more information than LC-MS.  LC-MS data plotted as 
mass versus retention time typically yields a scatter plot, while CE-MS results in data 
with well defined charge-based trends.16, 20, 86, 100 These trends are dependent upon the 
number of basic residues present, in effect providing compositional information for each 
peptide; this additional information adds confidence in assigning the peptide sequence.  
As mentioned from the α-casein data, tryptic phosphopeptides with no missed cleavages 
tend to reside along the +1 trend and are easily selectable from the plot. In a complex 
proteomic mixture, the search for tryptic phosphopeptides can be simplified to a list of 
candidate phosphopeptides. These selected candidates that reside on the +1 trend can 
then be submitted to tandem MS analysis using an inclusion mass list for the peptides of 
interest, cutting the analysis time for that PTM by more than one order of magnitude.  
This would also be true for other negatively charged PTMs. A major benefit of coupling 
separations off-line with MALDI-MS is the ability to re-interrogate the CE separation as 
needed. 
These charge-based trends also show specific utility towards protein 
identification in the case of limited tandem MS data. Proteolytic α-casein peptides 
denoted as (E, H, and L) in Figure 5b all have relatively low MS/MS ion scores. This 
insufficient tandem MS data may be due to a low abundance of these peptides or poor 
fragmentation chemistry. Additional physicochemical properties on these peptides can 
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be obtained upon examining the location of these peptides on the CE-MS charge-based 
trends (Figure 5a). The number of basic residues present in peptides (E, H, and L) is in 
agreement with the charge-based trend each peptide resides. Effectively, these charge-
based trends provide further confidence to assign the peptide identification. In addition, 
this CE-MS method can confirm questionable peptides with limited MS/MS data, hence 
a new way rule out false positives. For example, a peptide appears on the +3 trendline 
with a mass of 1871.9882 Da, this could be the αS2-casein peptide 
KTVDMESTEVFTKKTK with 5 ppm mass error. However, this peptide exists at the +5 
charge state. Given MS data alone, this peptide could be incorrectly identified based on 
mass accuracy. The added dimension from CE-MS allows for the removal of this false 
positive identification. The correct assignment for mass 1871.9882 m/z is the peptide 
YKVPQLEIVPNSAEER (1 ppm mass error), which migrates along the +3 charge-state 
trend as predicted. Overall, these charge-based trends add utility toward peptides with 
phosphorylations, similar mass, or insufficient tandem MS data. 
Peptides of similar mass, but different basic residue composition are easily 
identified.  For example, two peptides ADLNVPVKDGK (m/z 1155.626) and 
ASLPTIELALK (m/z 1155.698) derived from an E. coli lysate digest differ in mass by 
51 ppm. These two peptides are separated by 144 seconds in the CE dimension.  The 
separation in time is due to the difference in the number of basic residues, which can be 
determined in short by examining the charge-specific trend upon which each peptide 
resides, ADLNVPVKDGK (denoted as A in Figure 3) falls on the +3 trendline and 
ASLPTIELALK (denoted as B) falls on the +2 trendline as predicted. In effect providing 
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some compositional information for each peptide, this additional information adds 
confidence in assigning peptide sequence. 
 
Conclusion 
Trends observed in plots of m/z versus CE migration time for CE-MALDI-MS 
data were used in concert with two series of charge-state marker peptides to aid in 
charge state assignment. These 2D plots of CE-MALDI-MS data are simple and clear, 
providing compositional information on each peptide based on the peptides location on 
the plot. From the analysis of a proteolytic digest of α-casein, phosphopeptides were 
easily identifiable from deviations in the trends observed (which are predominantly non-
phosphorylated peptides).  Additionally, peptides with insufficient tandem MS data gain 
confidence in their identification owing to the added basic reside information. The 
overall simplicity of the 2D plots of the CE-MALDI-MS data we present offers 
advantages over LC-MS due to the reproducibility, clarity, and the information provided 
from the charge-state specific trends.  The coupling of CE with mass spectrometry is a 
powerful tool for proteomics which not only provides high-resolution, high efficiency 
separations, but the analysis also yields compositional information, charge state, and a 
streamlined process for analyzing charged PTMs. In addition, we plan to utilize 
bioinformatics technologies to create an automated process for analyzing CE-MS data of 
complex proteomic systems. 
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CHAPTER III 
HIGH-THROUGHPUT METHOD FOR ON-TARGET PERFORMIC ACID 
OXIDATION OF MALDI DEPOSITED SAMPLES* 
 
 
Introduction 
Disulfide bonds play important roles in stabilizing and maintaining native protein 
structure,49, 50 and mass spectrometry (MS) plays an increasingly important role in 
deciphering these processes,51 especially protein folding/unfolding kinetics.52-54 
Disulfide bond locations within proteins can be determined using a variety of MS-based 
methods including: tandem MS,57, 58  database search algorithms,56, 59-61  chemical 
reduction,55, 62, 63 chemical oxidation,46, 47, 64 and metal ion cleavage of disulfide-bonds.65, 
66 Xu and coworkers developed a tandem MS search engine to simplify database 
searches for disulfide-linked peptides fragment ion spectra,56 but such spectra can be 
complicated by direct cleavage of the disulfide bond between inter-linked disulfide 
bridged peptides, which results in a limited number of sequence-informative fragment 
ions from each peptide α and β-chain peptide forming the disulfide linkage.57 Disulfide-
linked peptides can also be identified through chemical reduction of the disulfide bond. 
 
__________________ 
* Reproduced with permission from Williams, B.J.; Russell, W.K.; Russell, D.H. High-
throughput on-target performic acid oxidation of MALDI deposited samples. J. Mass 
Spectrom. 2010, 45, 157-166. Copyright 2009 John Wiley & Sons Limited. (APPENDIX 
B) 
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For example, a reductive MALDI matrix, 1,5-diaminonapthalene (1,5-DAN),62 was used 
by Quinton and coworkers to characterize disulfide-bridged peptides using liquid 
chromatography (LC) coupled off-line with MALDI-MS/MS.63 This reductive MALDI 
matrix successfully reduces disulfide bonds during the MALDI process; however, 1,5-
DAN also yields a high relative abundance of matrix clusters up to 1000 m/z, which 
complicates the analysis of low molecular weight disulfide and/or cysteine-containing 
peptides.  
Chemical oxidation offers the following benefits over performing chemical 
reduction of the disulfide bond: (i) a 48 Da mass shift occurs per cysteine residue, (ii) 
cysteic acid (SO3H) enhances negative ion formation, and (iii) the performic acid 
simultaneously cleaves the disulfide bond and chemically modifies each peptide 
involved in the disulfide bridge. For example, performic acid oxidation has been used to 
study disulfide-containing proteins prior to proteolytic digestion and strong cation 
exchange (SCX) chromatography.47 The oxidized cysteine-containing peptides undergo 
an elution shift owing to a decrease in peptide solution-phase charge state, because low 
charge-state peptides are weakly retained on the SCX column. The resulting enriched 
oxidized cysteine-containing peptides are then subjected to off-line MALDI-MS/MS 
followed by peptide identification via database searching or de novo sequencing. This 
methodology utilizes a combination of oxidation, mass spectrometry, and database 
searching for analyzing the cleaved disulfide-bonds of bovine serum albumin. Because 
performic acid cleaves the disulfide bonds prior to digestion, the native disulfide bond 
pattern is lost; therefore, it is important to maintain intact disulfide-linked peptides 
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throughout proteolytic digestion in order to characterize the disulfide bond connectivity 
within proteins. 
Although performic acid oxidation is widely used, there are several challenges 
associated with solution-phase oxidation methods. For example, typical solution-phase 
oxidation methods are performed on lyophilized peptide/protein samples using reaction 
times ranging from 2-4 hrs47, 71, 72 and several steps are required following oxidation to 
remove the performic acid reagent prior to MS analysis.47, 71 Some solution-phase 
oxidation methods have decreased reaction times to 10-30 min for oxidation of 
cysteine/methionine containing peptides; however, the additional clean-up steps 
following oxidation make this method less desirable.46 On-target oxidation methods 
using solution-phase performic acid have also been successfully applied to MALDI spots 
containing peptides and/or proteolytic digests.71 For example, we showed that directly 
adding the performic acid solution to a pre-spotted MALDI deposit containing a bovine 
apo-transferrin tryptic digest yields oxidized tryptic peptides; however, the S/N ratios of 
the oxidized peptide negative ions decreased by 5-fold because of ion suppression 
effects. The overall amino acid sequence coverage also decreased by half compared to 
the solution-phase oxidized sample. Thus, an on-target performic acid oxidation method 
that can mitigate these adverse effects would be highly beneficial. The ideal on-target 
oxidation method would offer the following characteristics over solution-phase oxidation 
methods: (i) simple experimental procedure with no post-oxidation sample cleanup; (ii) 
decreased ion suppression effects following oxidation; (iii) improved throughput over 
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solution-phase methods; and (iv) maintain positive and negative ion mass spectral 
quality following on-target oxidation. 
This report describes an on-target performic acid oxidation method using 
performic acid vapor to oxidize disulfide-containing peptides/proteins deposited for 
MALDI-MS analysis. Brown and Hartley have reported a similar approach using 
performic acid vapor to oxidize disulfide-linked peptides on electrophoresis paper.101 
The novel aspect of our method is found within the ability to successfully oxidize 
multiple MALDI spots simultaneously using performic acid vapor contained within a 
reaction chamber without sample cleanup. Reaction times for the on-target performic 
acid oxidation method (10-60 min) are also shorter than traditional solution-phase 
oxidation methods (2-4 hrs). We apply this on-target performic acid oxidation method to 
a model disulfide-linked peptide, intact bovine insulin, and a proteolytic digest of bovine 
ribonuclease A. In addition, we discuss the advantages of this method over solution-
phase oxidation methods and demonstrate the ability to elucidate disulfide-linked 
peptides from ribonuclease A. 
 
Experimental 
Chemicals 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless 
otherwise noted. Sequencing grade modified trypsin was obtained from Promega 
(Madison, WI). Oxytocin (CYIQNCPLG-NH2) was purchased from American Peptide 
Company (Sunnyvale, CA). Hydrogen peroxide (35% w/w) and formic acid (99% w/w) 
  38  
were obtained from Acros Organics (Morris Plains, NJ). HPLC grade acetone, 
acetonitrile (CH3CN), and methanol (CH3OH) were purchased from EMD Chemicals 
Inc. (Gibbstown, NJ). All experiments were performed with 18-MΩ water (ddH2O) 
purified using a water purification unit (Barnstead International, Dubuque, IA).   
 
Sample Preparation for MALDI-MS 
A 15 µM stock solution of native oxytocin was prepared in 10 mM formic acid. 
Oxytocin was reduced by adding 2 µL of 50 mM tris(2-carboxyethyl)phosphine and 
incubating at 60˚C for 60 min. The synthetic mixture of native and reduced oxytocin (1:1 
molar ratio of native: reduced oxytocin) was reacted with 2-iodoacetamide by increasing 
the solution pH from 3.0 to 7.1 with 40 µL of 25 mM ammonium bicarbonate 
(NH4HCO3) and incubated in the dark for 45 min at room temperature. The excess 2-
iodoacetamide and NH4HCO3 was removed using a 10 µL C18 resin pipette tip 
(Millipore, Billerica, MA) and eluted with a 60:40 CH3CN: ddH2O solution containing 
0.1% formic acid. A 1 µL aliquot of the eluate was spotted as the overlayer (analyte 
deposited on pre-spotted MALDI matrix) to α-cyano-4-hydroxycinnamic acid (CHCA) 
matrix. CHCA was prepared at 5 mg mL-1 in a 2:3 ddH2O: CH3OH solution containing 
10 mM dihydrogen ammonium phosphate (NH4H2PO4) and 1 µL was pre-spotted using 
the underlayer method.90 
Stock solutions of α-melanocyte stimulating hormone (Ac-
SYSMEHFRWGKPV-NH2) and α1-mating factor (WHWLQL) were prepared at 10 µM 
in 10 mM formic acid. The resulting solutions were then mixed 1:1 (v/v) with CH3OH 
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and 1 µL (5 pmol) was spotted onto the MALDI target as an overlayer to CHCA matrix. 
These MALDI deposits were initially oxidized using the on-target oxidation methods 
described below (-20˚C for 60 min). Additional oxidation was performed on the same 
MALDI deposits using room temperature (+24˚C) oxidation for an additional 60 
minutes.  
A stock solution (1 mg mL-1) of bovine insulin was diluted to 10 µM in 10 mM 
formic acid. The insulin solution was then mixed 1:1 (v/v) with CH3OH and 1 µL (5 
pmol) was spotted onto the MALDI target as an overlayer to pre-spotted MALDI matrix. 
The on-target oxidation experiments using intact insulin were performed with three 
different MALDI matrices: CHCA, 2,4-dihydroxyacetophenone (2,4-DHAP), and 2,4-
DHAP combined with CHCA as dual MALDI matrices. For the experiments with 
CHCA and 2,4-DHAP (10 mg mL-1 in 2:3 ddH2O: CH3OH with 10 mM NH4H2PO4), the 
pre-spotted MALDI deposit was re-dissolved with an overlayer of insulin (1 µL of 5 µM 
insulin in 1:1 (v/v) CH3OH: 10 mM formic acid). For the dual MALDI matrices 
experiment, 2,4-DHAP was spotted as an underlayer followed by an overlayer of insulin 
then subjected to on-target oxidation. Following oxidation, the 2,4-DHAP + insulin 
sample deposit was re-dissolved with overlayer of CHCA prior to MS analysis. The 
intact insulin experiments with the varied MALDI matrices were oxidized using the on-
target performic acid oxidation methods described below with the exception of 
performing oxidation at room temperature (+23˚C) for 60 minutes. 
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Ribonuclease A Proteolytic Digestion 
Dual protease digestion (trypsin followed by chymotrypsin) of bovine 
ribonuclease A (RNase A) was performed using methods described by Xu and 
coworkers with minor modifications.56 Briefly, RNase A was dissolved at 1 mg mL-1 in 
a 25 mM ammonium acetate buffer adjusted to pH 6.0 with 10 mM formic acid. RNase 
A was initially digested with trypsin (1:50 (w/w) enzyme: protein ratio) for 4 hrs at 37˚C 
followed by chymotrypsin addition (1:50 (w/w) enzyme: protein ratio) and incubated for 
an additional 4 hrs.  The RNase A proteolytic digest was alkylated following proteolytic 
digestion with 5 µL of 100 mM 2-iodoacetamide and incubating in the dark for 45 min at 
room temperature. Following alkylation, the sample was subjected to cleanup using a 10 
µL C18 resin pipette tip. The RNase A proteolytic digest was eluted with a 60:40 
CH3CN: ddH2O solution containing 0.1% formic acid and 1 µL of the eluate was spotted 
as the overlayer to CHCA matrix.  
 
On-Target and Solution-Phase Performic Acid Oxidation 
 Performic acid was prepared using hydrogen peroxide (35% w/w) and formic 
acid (99% w/w) mixed at a 1:9 ratio, respectively, and allowed to age at room 
temperature for 2 hr.71 On-target performic acid oxidation using performic acid vapor 
was performed by placing 40 µL of a 1:1 (v/v) mixture of acetone: performic acid 
directly on the MALDI target in an area that does not contain sample (distance from the 
performic acid reagent to the MALDI sample deposit is not critical). The MALDI target 
was then covered in a plastic petri dish and placed in a -20˚C freezer for 10-60 min. 
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Following on-target performic acid oxidation the MALDI plate was allowed to reach 
ambient temperature then subjected to MALDI analysis without sample cleanup. 
Solution-phase performic acid oxidation was performed using a 1:19 ratio of hydrogen 
peroxide: formic acid as previously described.69  The performic acid solution was used 
to resuspend vacuum dried peptide samples or RNase A proteolytic digests then allowed 
to react at 0°C for 4 hr. Following oxidation, samples were diluted with 500 µL of 
ddH2O and vacuum dried. Samples were then resuspended in ddH2O and mixed 1:1 (v/v) 
with CH3OH prior to spotting on the MALDI target as an overlayer.  
 
MALDI-MS and MALDI-MS/MS 
All MALDI-MS experiments were performed using a model 4700 Proteomics 
Analyzer MALDI-TOF/TOF (Applied Biosystems, Framingham, MA). The MALDI-MS 
data were acquired using the reflectron detector in both positive and negative ion modes 
using 1200 laser shots with external calibrants: bradykinin (2-9) (PPGFSPFR) and 
adrenocorticotropic hormone (ACTH) (18-39) (RPVKVYPNGAENESAEAFPLEF). 
Two different instrument parameters were used for MS experiments with 
peptides/proteolytic digests (500-4500 Da, 2100 Da focus mass) and intact bovine 
insulin (700-6000 Da, 3500 Da focus mass). The non-oxidized forms of RNase A 
proteolytic peptides, 118YPNCAY123 and 73VHESLADVQAVCSQK87 were used to 
internally calibrate the negative ion mass spectrum of the RNase A proteolytic digest. 
Collision-induced dissociation (CID) tandem MS spectra were acquired using 20% 
greater laser power than the MS spectra acquisition with atmosphere (medium pressure) 
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as the collision gas with 1 kV of collision energy. The average coefficient of variation 
(CV) was calculated to be ±6% for triplicate analysis of an RNase A proteolytic digest 
subjected to on-target oxidation. Normalized ion signals were determined using a ratio of 
the single peptide ion count to the total ion count for five oxidized RNase A peptides. 
The normalized ion signals were then used to calculate the CV.  
 
Results and Discussion 
 The main motivation of this work is to develop a method to simultaneously scan 
complex mixtures for disulfide-linked peptides and be able to distinguish between free 
cysteine and bridged disulfide-containing peptides. Our strategy is to use thiol alkylation 
chemistry followed by on-target performic acid oxidation. Scheme 1 illustrates the 
resulting performic acid oxidation products for both (a) inter-linked and (b) intra-linked 
disulfide-containing peptides. For example, an inter-linked disulfide bridged peptide will 
form oxidized products for both α and β-chain peptides (Scheme 1a). The performic acid 
cleaves the disulfide bond to convert each cysteine thiol to cysteic acid (SO3H), whereas 
an intra-linked disulfide containing peptide will form a single peptide containing two 
cysteic acid residues (Scheme 1b). Note that a peptide containing two free thiol side 
chains will yield the same product as Scheme 1b. Incorporating an alkylation reagent 
such as 2-iodoacetamide into the overall reaction scheme provides differentiation 
between peptides with two free cysteine residues or an intra-linked disulfide bond. The 
carbamidomethyl (CAM) group protects the free cysteine residues from oxidation, while 
the intra-linked disulfide bridged peptide will be fully oxidized (Scheme 1c).  
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Scheme 1. Performic acid oxidation products of (a) inter-linked and (b) intra-linked 
disulfide-linked peptides, and (c) a mixture of an intra-linked disulfide-linked 
peptide and the 2-iodoacetamide alkylated form. 
 
 
 
On-Target Oxidation of Oxytocin 
The disulfide-containing peptide oxytocin (CYIQNCPLG-NH2) is used to 
illustrate the reaction shown in Scheme 1c, and a synthetic mixture of native and 
chemically reduced oxytocin is used to demonstrate the mixture described in Scheme 1b. 
The synthetic mixture of native and reduced oxytocin was reacted with 2-iodoacetamide, 
and Figure 7 contains (a) positive and (b) negative ion MALDI-MS spectra for this 
sample taken after on-target performic acid oxidation of the native and CAM-modified 
oxytocin mixture. Ion signals for native oxytocin (m/z 1007.48 for [M + H]+) and signals 
for alkylation products (m/z 1066.53 for [M + H + CAM]+ and m/z 1123.55 for [M + H 
+ 2CAM]+) are observed in the positive ion mass spectrum after oxidation (Figure 7a). 
These assignments were confirmed by tandem MS (Figure 8b and Figure 8c). The intact 
disulfide bond of native oxytocin is cleaved and converted to cysteic acid, as evidenced 
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by the [M – H + O6]- ion (m/z 1103.37) in the negative ion mass spectrum (Figure 7b). 
The negative ion tandem mass spectrum for fully oxidized oxytocin can be found in 
Figure 8a. Following oxidation [M + H]+ ions of native oxytocin are still observed in the 
positive ion mass spectrum (Figure 7a), which suggests incomplete oxidation of native 
oxytocin. Experiments are currently underway to address issues related to incomplete 
oxidation, and preliminary data for these on-target oxidation optimization studies are 
discussed below. Despite incomplete conversion to the fully CAM-modified oxytocin, 
ion signals for [M + H + CAM + O3]+ or [M - H + CAM + O3]- are not observed in the 
positive or negative ion mass spectra. Therefore, the single CAM-modified oxytocin 
does not complicate the differentiation between a peptide that contains two free cysteine 
residues from one that contains an intra-linked disulfide bond. Nonetheless, the 2-
iodoacetamide alkylation chemistry incorporated into Scheme 1c allows a multiple free 
cysteine-containing peptide to be differentiated from an intra-linked disulfide bridged 
peptide such as oxytocin. 
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Figure 7. (a) Positive ion and (b) negative ion mass spectrum of native and CAM-
modified oxytocin after 10 minutes of on-target performic oxidation performed at -20˚C. 
 
Effect of On-Target Oxidation on His, Met, Trp, and Tyr Containing Peptides 
The effect of on-target oxidation on peptides that contain other oxidizable amino 
acids, such as histidine, methionine, tryptophan, and tyrosine was investigated using α-
melanocyte stimulating hormone (Ac-SYSMEHFRWGKPV-NH2) and α1-mating factor 
(WHWLQL). Figure 9a contains a positive ion mass spectrum for α-melanocyte 
stimulating hormone taken before oxidation. Note that several oxidized peptide ion 
signals ([M + H + O]+, [M + H + O2]+, etc.) are present in this spectrum. These oxidized 
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ion signals are a result of oxidation owing to air exposure over time. Following on-target 
oxidation (1 hr at -20˚C) (Figure 9b), the intensities of the oxidized peptide ion signals 
do not increase relative to the [M + H]+ ion, thus it appears that on-target oxidation does 
not significantly oxidize other amino acids under cold oxidation conditions. The same 
MALDI sample deposit was subjected to an additional hour of oxidation at + 24˚C and 
the abundance of the oxidized ion signals do not increase relative to the [M + H]+ ion 
signal for α-melanocyte stimulating hormone, thus it appears that oxidation is not 
occurring (Figure 9c). As a control experiment, native oxytocin (CYIQNCPLG-NH2) 
was spotted on a separate sample deposit and oxidized simultaneously on the same 
MALDI target, and the MALDI mass spectrum from this sample contains a strong signal 
for the [M – H + O6]- ion (m/z 1103.44) (Figure 9d) indicating the oxidation reaction 
was successful. Similar experiments for α1-mating factor also resulted in minimal 
increase in the relative abundance of the oxidized peptide ion signals as a result of 
oxidation (See Figure 10), thus we conclude that the on-target oxidation is not 
complicated by reactions with H, M, W, or Y amino acid containing peptides. 
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Figure 8. (a) Negative ion tandem mass spectrum for fully oxidized oxytocin [M – H + 
O6]- (CoxYIQNCoxPLG-NH2). Positive ion tandem mass spectra for the carbamidomethyl 
(CAM) modified oxytocin ion signals (b) [M + H + CAM]+ and (c) [M + H + 2CAM]+.  
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Figure 9. Typical positive ion mass spectra for α-melanocyte stimulating hormone (Ac-
SYSMEHFRWGKPV-NH2) (a) before and (b) after an hour of on-target performic acid 
oxidation at -20˚C. Panel (c) represents an additional hour of on-target oxidation 
performed on the same sample deposit at +24˚C. Panel (d) contains a negative ion mass 
spectrum of a control experiment performed using native oxytocin (CYIQNCPLG-NH2) 
oxidized in parallel with α-melanocyte stimulating hormone on the same MALDI target. 
Ion signals denoted with closed diamonds (♦) represent contaminate ions arising from 
the CHCA matrix. 
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Figure 10. Typical positive ion mass spectra for α1-mating factor (WHWLQL) (a) 
before and after (b) an hour of on-target performic acid oxidation at -20˚C. Panel (c) 
represents an additional hour of on-target oxidation performed on the same sample 
deposit at +24˚C. Panel (d) contains a negative ion mass spectrum of a control 
experiment performed using native oxytocin (CYIQNCPLG-NH2) oxidized in parallel 
with α1-mating factor on the same MALDI target. Ion signals denoted with closed 
diamonds (♦) represent contaminate ions arising from the CHCA matrix. 
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On-Target Oxidation of Intact and Reduced Insulin 
Bovine insulin is an excellent model system to illustrate on-target performic acid 
oxidation of disulfide-containing proteins because it contains three disulfide bonds, two 
inter-chain disulfide bonds, which link the α and β-chains and one intra-chain disulfide 
bond within the α-chain (see below). Performic acid should cleave both the intra and 
inter-linked disulfide bonds to fully oxidize both α and β-chains.  
 
Figure 11 contains the negative ion mass spectra of oxidized intact insulin 
obtained using several different sample preparation methods. The spectrum contained in 
Figure 11a contains a strong ion signal for the fully oxidized β-chain [β – H + O6]- at m/z 
3492.83, but under these conditions ion signals for the fully oxidized insulin α-chain are 
not observed in either positive or negative ion spectra. On the other hand, ion signals at 
m/z 2463.08 are most likely partially oxidized α-chain, [α – H + O9 – 17]-calc = 2463.89 
Da (-333 ppm mass error) or [α – H + O8]-calc = 2463.94 Da (-353 ppm mass error), but 
we were unable to confirm these assignments by using tandem MS owing to the low 
abundance of the signals. Note that oxidation of chemically reduced insulin yields 
abundant ion signals for both α- and β-chains, i.e., the fully oxidized insulin α-chain [α – 
H + O12]- ion at m/z 2528.67 and β-chain [β – H + O6]- ion at m/z 3492.34 are observed 
in the negative ion mass spectrum (Figure 11b). 
Figure 11c contains the negative ion mass spectra for oxidized intact insulin from 
2,4-DHAP, and  Figure 11d contains similar spectra obtained from 2,4-DHAP prepared 
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using an overlayer of CHCA. When on-target oxidation is performed on deposits of 2,4-
DHAP, the fully oxidized insulin α-chain [α – H + O12]- and β-chain [β – H + O6]- ions 
are observed in the negative ion mass spectrum (Figure 11b). Note that the negative ion 
yields for both α- and β-chain oxidized forms are enhanced using 2,4-DHAP/CHCA 
sample preparation. The signal-to-noise ratio of the oxidized insulin α-chain increases 
1.5-fold for the dual MALDI matrix method relative to using 2,4-DHAP as a MALDI 
matrix alone. 
It appears that efficient oxidation of intact insulin to form oxidized α and β-
chains is related to greater accessibility of the performic acid vapor to oxidize the insulin 
molecules within the 2,4-DHAP crystals. The presence of non-oxidized intact insulin 
ions following oxidation could indicate that insulin molecules are trapped within CHCA 
crystals, probably as inclusion complexes,102 whereas with 2,4-DHAP, the insulin 
molecules are located on the 2,4-DHAP crystal surface and become more susceptible to 
oxidation (Figure 11c). Further investigation of different MALDI matrices used for the 
on-target performic acid oxidation method may provide additional insight to explain why 
some cysteine and/or disulfide-containing peptides are more readily oxidized.103 
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Figure 11. Negative ion mass spectra after on-target oxidation of (a) intact insulin and 
(b) chemically reduced insulin using CHCA as the MALDI matrix during oxidation. 
Panel (c) 2,4-DHAP was used as the MALDI matrix during on-target oxidation of intact 
insulin. Panel (d) 2,4-DHAP was used during oxidation followed by an overlayer 
addition of CHCA which we found improve the yield of negative ions. 
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On-Target Oxidation of RNase A Proteolytic Digest 
RNase A is an excellent model protein to study disulfide bonds in proteins 
because it contains eight cysteine residues, each present as disulfide bonds.46, 56, 69 RNase 
A contains four native disulfide bonds, three disulfide bonds are inter-linked and the 
other disulfide bond is intra-linked. Our experimental design involves performing 
proteolytic digestion under mildly acidic conditions (pH 6) to minimize disulfide 
scrambling56 combined with 2-iodoacetamide alkylation chemistry to protect the free-
cysteine residues (i.e., disulfide-linked peptides that may become reduced during 
digestion) from oxidation. Following proteolytic digestion, the intact disulfide-
containing peptides are then subjected to on-target performic acid oxidation where the 
disulfide bond(s) are cleaved to form two peptides each containing a cysteic acid side 
chain (See Scheme 1a). Each oxidized peptide chain is then subjected to tandem MS, 
where the amino acid sequences of the two peptide chains forming the disulfide-bond 
can be determined. 
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Figure 12 contains negative ion mass spectra for the RNase A 
trypsin/chymotrypsin digest + 2-iodoacetamide acquired (a) before oxidation, (b) after 
on-target and (c) solution-phase oxidation. For this example, the on-target oxidation was 
performed for 1 hr at -20˚C and the solution-phase oxidation was performed for 4 hrs at 
0˚C. Fourteen new peptide ion signals resulting from performic acid oxidation are 
observed and those confirmed by tandem MS are labeled A-J (Figure 12b), while the 
four additional ion signals too low in abundance to characterize by tandem MS are 
labeled with asterisks (*). The tandem MS confirmed amino acid sequences of the 
oxidized RNase A peptides are summarized in Table 1. Several cysteine-containing 
peptides 52CoxNQMMK57, 93NGQTNCoxY99, and 88NVACoxK92 only appear after 
oxidation, which is most likely a result of oxidative cleavage of the intact disulfide-
linked peptides. Proteolytic peptides containing methionine residues (e.g., 
52CoxNQMMK57 and 52CoxNQMM56) were also oxidized owing to the incorporation of 
two additional oxygen atoms per methionine residue (denoted in bold italics). Ten total 
oxidized peptides accounting for all eight RNase A cysteine residues involved in 
disulfide bonds were detected using on-target oxidation, whereas a total of eight (six of 
these peptides are involved in disulfide bridging) oxidized RNase A peptides were 
detected using solution-phase oxidation. Comparing the mass spectral quality of the on-
target (Figure 12b) and solution-phase oxidation (Figure 12c) method clearly illustrates 
an advantage of the on-target oxidation method. At first glance the on-target oxidation 
method (Figure 12b) appears to contain additional chemical noise above m/z 1000; 
however, the majority of these ion signals correspond to [M – H]- ions for intact 
  55  
disulfide-linked peptides that are present after oxidation. As for the solution-phase 
oxidation method (Figure 12c), these ion signals from m/z 1000-2000 are not observed 
because these intact disulfide-linked peptides have undergone oxidative cleavage to 
produce small oxidized cysteine-containing peptides. In terms of signal-to-noise 
improvement, the S/N ratios for the labeled ion signals increase an average 2.5-fold for 
the on-target oxidation method relative to the solution-phase oxidation method. A drastic 
S/N enhancement occurs for peptide I (131HIIVACoxEGNPY141) where the ratio of the 
S/N values for the on-target oxidation method improves ca. 6-fold over the solution-
phase oxidation method. The decrease in relative abundance for the solution-phase 
oxidation method could be attributed to ion suppression effects or sample loss associated 
with post-oxidation vacuum drying prior to MS analysis. Overall, the RNase A negative 
ion MS data suggests that the on-target oxidation method is suitable for proteolytic 
protein digests.  
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Figure 12. Negative ion mass spectra for an RNase A trypsin/chymotrypsin + 2-
iodoacetamide digest a) before and b) after on-target performic acid oxidation and c) 
solution-phase oxidation. The peptides denoted with asterisks (*) correspond to new 
peptide ion signals resulting from performic acid oxidation not confirmed by tandem 
MS. The peptide ion signals denoted with closed diamonds (♦) indicate chemical 
contaminates arising from the CHCA matrix. 
 
 
 
 
 
  57  
 
 
 
 
 
 
 
 
 
Table 1. Summary of Negative Ion MALDI-MS Data Resulting from On-Target 
Performic Acid Oxidation of RNase A Tryptic/Chymotryptic Peptides  
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Figure 13. (a) Positive ion mass spectrum of the RNase A trypsin/chymotrypsin digest + 
2-iododacetamide following on-target oxidation. Inset figure: expanded view of mass 
range 1315-1335 m/z. (b) Table correlating the observed oxidized cysteine-containing 
peptides with their resulting candidate inter-linked disulfide bridged peptides.  
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Several disulfide-linked peptides can be elucidated from the observed oxidized 
cysteine-containing peptides summarized in Table 1. The correlation of the non-oxidized 
peptide masses and the calculated disulfide-linked peptide masses is shown in Figure 
13b. The peptides are arranged according to increasing mass to form an array of 
calculated disulfide-linked peptide masses. All the different disulfide-linked peptide 
bridging possibilities are calculated from the list of peptide m/z values accounting for the 
mass difference of an inter-linked disulfide bond. The calculated disulfide-linked peptide 
masses that match an ion signal present in the positive ion mass spectrum of the oxidized 
RNase A trypsin/chymotrypsin digest (Figure 13a) are indicated with a box around the 
number. For example, an ion signal at m/z 1535.56 is present in the positive ion mass 
spectrum which corresponds to the disulfide-linked peptide (118YPNCAY123 / 
66CKPVNTF72) which is a native disulfide linkage between Cys66 and Cys121. This 
assignment was further confirmed by tandem MS by observing several b-type fragment 
ions and the signature fragment ions for an inter-linked disulfide bond. The ion signal at 
m/z 1677.66 is most likely the disulfide-linked peptide (84CSQK87 / 
131HIIVACEGPNY141) with an [M + H]+calc = 1677.77 Da (-67 ppm mass error) and a 
170.09 Da mass difference (Ala-Val residue mass = 170.11 Da) from the m/z 1847.75 
ion signal. All four native disulfide bonds from RNase A can be elucidated from the 
oxidized cysteine-containing peptides resulting from the on-target oxidation of the 
RNase A proteolytic digest. At this point we are not claiming a method for complete 
disulfide-bond elucidation from a single MALDI deposit; there are several other possible 
RNase A disulfide-linked peptides that can be produced from different proteolytic 
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digestion products that were not identified. Therefore, we plan to further expand on the 
disulfide bond elucidation capability using this on-target oxidation method in 
combination with CE-MALDI-MS to deconvolute the negative ion mass spectra prior to 
oxidation.  
 
Conclusion 
 On-target oxidation using performic acid vapor was achieved for MALDI 
deposited samples containing model disulfide-linked peptides, intact insulin, and a 
proteolytic digest of RNase A. Cysteine, cystine, and methionine amino acid side chains 
are readily oxidized after on-target oxidation. On the other hand, other oxidizable amino 
acids such as histidine, tryptophan, and tyrosine are not significantly oxidized as a result 
of on-target oxidation. The oxytocin experiments demonstrate the compatibility of the 
on-target oxidation method with alkylation chemistry to distinguish between a peptide 
containing two free-cysteine residues from a peptide with a single intra-linked disulfide 
bond. The intact insulin experiments illustrate the ability to oxidize small disulfide-
containing proteins and suggest that the MALDI matrix plays a role in the oxidation 
process by the matrix crystals affecting the ability of the performic acid vapor to reach 
the analyte. All four native RNase A disulfide bonds were successfully elucidated from 
the negative ion MALDI-MS data from the on-target performic acid oxidation of an 
RNase A proteolytic digest. 
The on-target oxidation method is advantageous over solution-phase oxidation 
methods because of the decreased sample handling and reaction time. Another major 
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benefit of the on-target oxidation method is the ability to perform simultaneous 
oxidation of several MALDI sample deposits. In addition, the positive and negative ion 
mass spectral quality is not sacrificed following oxidation. The on-target performic acid 
oxidation method provides a very powerful technique to distinguish between free-
cysteine containing peptides and those peptides that contain disulfide bonds. 
Additionally, this method will make a drastic impact for disulfide-linked peptide 
characterization from complex mixtures, owing to the ability to rapidly screen an entire 
MALDI target for sample deposits that contain enhanced negative ion signals, i.e., these 
are MALDI spots that may contain candidate disulfide-linked peptides. Hence, the 
motivation to combine the on-target oxidation method with off-line separations (e.g., 
capillary electrophoresis or liquid chromatography) coupled with MALDI-MS19, 85 to 
analyze disulfide-linked peptides from complex proteomic mixtures.  
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CHAPTER IV 
EVALUATION OF EXPERIMENTAL VARIABLES FOR THE ON-TARGET 
OXIDATION OF CYSTEINE-CONTAINING PEPTIDES AND PROTEINS 
 
Introduction 
Cysteine oxidation in proteins can occur during a time of oxidative stress and 
more importantly these oxidized cysteine residues may play important biological and 
pathological roles.36-39  For example, in kinase enzymes, cysteine oxidation away from 
the active site causes the oxidized cysteine to form a disulfide bond with a nearby 
cysteine residue, thus changing the protein conformation and therefore enzymatic 
activity.35 The thiol side chain of cysteine can exist in several oxidized forms including: 
disulfide bonds (R-S-S-R), sulfenic (RSOH), sulfinic (RSO2H), or sulfonic (RSO3H) 
acids. An estimated 5% of cellular protein cysteine residues occur in the sulfinic or 
sulfonic acid form.104 Sulfenic acids are known to have short lifetimes before they 
undergo disulfide bond formation or further oxidation to sulfinic or sulfonic acids. 
Technologies to capture sulfenic acids using dimedone (i.e., 5,5-dimethyl-1,3-
cyclohexadimone) chemistry followed by antibody recognition and mass spectrometry 
(MS) analysis have been reported.36-38, 41, 42 The detection of the final cysteine oxidation 
product, sulfonic acid is rather straightforward to detect since the oxidation is 
irreversible and MS-based detection schemes have proven to be effective.44, 45-48For 
example, we recently published an on-target performic acid oxidation method which can 
readily form cysteic acid-containing peptides using performic acid vapor to oxidize 
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MALDI deposited samples.48 The intact disulfide bonds are broken via oxidative 
cleavage to produce two new peptides each containing a cysteic acid. From the resulting 
oxidized cysteine-containing peptides observed in the negative ion mass spectra we are 
able to elucidate intact disulfide-linked peptides from bovine Ribonuclease A. However, 
the various experimental parameters (e.g., temperature, exposure time, and MALDI 
matrix) associated with the on-target oxidation method were not extensively evaluated to 
improve the oxidized peptide yield. 
The motivation to investigate the on-target oxidation experimental parameters 
was inspired by initial difficulty completely oxidizing intact insulin to form oxidized α- 
and β-chains.48 The insulin β-chain readily oxidizes on the surface (co-crystallized with 
MALDI matrix) of the MALDI target when exposed to performic acid vapor. However, 
the insulin α-chain required an alternative MALDI matrix during on-target oxidation in 
order to be successfully oxidized. Analyte-matrix inclusion complexes 102 with α-cyano-
4-hydroycinnamic acid are suspected to inhibit α-chain oxidation. Another hypothesis 
could be related to the increased analyte size causing the matrix crystals to grow less 
oriented; therefore, the voids in the crystal lattice become large in number and smaller in 
size.105 Additionally, some MALDI matrices are known (e.g., 2,6-dihydroxybenzoic 
acid) to exclude the protein molecule from the crystal lattice,106, 107 which could prevent 
performic acid vapor exposure. Therefore, we chose to evaluate several commonly used 
MALDI matrices to effectively change the type of analyte-matrix crystal lattice. 
 Herein we investigate the effect of various experimental variables associated 
with the on-target oxidation experiment. The effect of oxidation temperature, performic 
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acid exposure time, and varying the MALDI matrix during oxidation are investigated. 
Standard cysteine-containing peptides (e.g., Cys-kemptide, Arg8-Vasopressin, and Cys8-
renin) and intact bovine insulin were used for these on-target oxidation studies with 
varied experimental conditions. In addition, this on-target oxidation method was adapted 
towards on-target oxidation of disulfide-containing proteins (e.g., bovine pancreatic 
trypsin inhibitor) followed by on-target proteolytic digestion to enhance the digestion 
efficiency. 
 
Experimental 
Chemicals 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless 
otherwise noted. Hydrogen peroxide (35% w/w) and formic acid (99% w/w) were 
purchased from Acros Organics (Morris Plains, NJ). HPLC grade acetone and methanol 
(CH3OH) were purchased from EMD Chemicals Inc. (Gibbstown, NJ). All experiments 
were performed with 18-MΩ water (ddH2O) purified using a water purification unit 
(Barnstead International, Dubuque, IA).   
 
Sample Preparation for MALDI-MS 
A stock solution of cys-kemptide (CLRRASLG) was prepared at 10 µM in 10 
mM formic acid. To remove disulfide-linked contaminant, the Cys-kemptide stock 
solution was reduced with tris(2-carboxyethyl)phosphine (50 mM prepared in ddH2O) 
by incubating at 60˚C for 60 min. The peptide solution was mixed 1:1 with CH3OH and 
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1 µL was spotted as an overlayer to MALDI matrix. Each MALDI matrix (2,4-
dihydroxyacetophenone, 2,5-dihydroxybenozic acid, 4-hydroxy-α-phenylcinnamic acid, 
4-hydroxy-α-cyanocinnamic acid, and 3,5-dimethyl-4-hydroxycinnamic acid) were 
prepared at 5 mg mL-1 in a 2:3 ddH2O: CH3OH solution containing 10 mM NH4H2PO4 
and 1 µL was pre-spotted as the underlayer.90 This cysteine-containing peptide was later 
oxidized using the on-target oxidation procedures described below. 
 
On-Target Performic Acid Oxidation 
 On-target oxidation was performed as described previously.48 Briefly, 40 µL of a 
1:1 mixture of acetone: performic acid was placed directly on the MALDI target in a 
region that does not contain sample. The MALDI target was then covered in a plastic 
petri dish and was allowed to react at three different temperatures (-20˚C, +25˚C, and 
+50˚C) with reaction times ranging from 10-60 min. Following on-target performic acid 
oxidation the MALDI plate is then subjected to MALDI analysis without sample 
cleanup. The on-target oxidation experiments with intact insulin were performed using 
room temperature oxidation (+23˚C) for 60 minutes. The cys-kemptide on-target 
oxidation experiments were performed at +23˚C for 15 minutes. 
 
On-Target Proteolytic Digestion 
 On-target proteolytic digestion was performed similar to as previously 
described.108 Briefly, following on-target oxidation of the intact protein in the presence 
of 2,4-DHAP trypsin was added at a 1:20 (w/w) enzyme: protein ratio. A 1 µL aliquot of 
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the trypsin solution (5 mM NH4HCO3 buffer with 50% CH3OH) was added to the 
MALDI deposit and placed in a humidity chamber at 37˚C for 60 minutes. Following 
on-target proteolytic digestion, an additional deposit of CHCA was added to each 
MALDI sample prior to MS analysis. 
 
MALDI-MS and MALDI-MS/MS 
All MALDI-MS experiments were performed using a model 4700 Proteomics 
Analyzer MALDI-TOF/TOF (Applied Biosystems, Framingham, MA). The MALDI-MS 
data were acquired using the reflectron detector in both positive and negative ion modes 
using 1200 laser shots with external calibration using bradykinin (2-9) (PPGFSPFR) and 
ACTH (18-39) (RPVKVYPNGAENESAEAFPLEF). Positive and negative ion 
collision-induced dissociation (CID) tandem MS spectra were acquired using 10-20% 
greater laser power than the MS spectra acquisition with atmosphere (medium pressure) 
as the collision gas with 1 kV of collision energy. 
 
Results and Discussion 
The major goal of these on-target oxidation experimental variable studies is to 
improve the overall oxidation efficiency through varying the conditions of the on-target 
oxidation experiment. Specifically, we investigate the effect of altering the (i) oxidation 
temperature, (ii) performic acid exposure time, and (iii) the MALDI matrix during 
oxidation. We also demonstrate the feasibility of performing on-target oxidation of intact 
disulfide-containing proteins followed by on-target proteolytic digestion. The native 
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disulfide bond pattern would be lost using this approach; however, a protein that has 
inaccessible (e.g., bovine pancreatic trypsin inhibitor) proteolytic cleavage sites will now 
be easily digested on the MALDI target. 
 
Effect of Oxidation Temperature 
 Initial on-target oxidation experiments were performed using cold oxidation 
temperatures (-20˚C) to prevent undesired oxidation of histidine, tryptophan, and 
tyrosine amino acid residues.  Three standard peptides: Arg8-vasopressin 
(CYFQNCPRG-NH2), α-melanocyte stimulating hormone (Ac-SYSMEHFRWGKPV-
NH2) , and Cys8-renin (DRVYIHPCHLLYYS) were used to further investigate the effect 
of oxidation temperature. This experiment is designed to oxidize the cysteine-containing 
peptides with minimal oxidation products of α-melanocyte stimulating hormone (α-
MSH) as the temperature increases.  
Figure 14 contains the negative ion mass spectra (a) before and after on-target 
oxidation of these standard peptides performed at (b) -20˚C, (c) +25˚C, and (d) +50˚C. 
Notice that some oxidation products from α-MSH ([B – H + O]-) and Cys8-renin ([C – H 
+ O3]-) are observed prior to oxidation. Arg8-vasopressin readily oxidizes within the 
peptide mixture to produce [A – H + O6]- ions at m/z 1180.40 with an improved negative 
ion yield because of the two cysteic acid groups drastically increase the peptide acidity. 
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Three oxygen atoms are also incorporated into Cys8-renin to produce the [C – H + O3]- 
ion at m/z 1824.82. Figure 14d illustrates that several α-MSH oxidation products are 
present when the oxidation is performed at elevated temperatures. For example, the 
relative abundance of the [B – H + O6]- ion increases as the oxidation temperature 
increases. Relative to the oxidation performed at or below +25˚C there is additional 
chemical noise present in Figure 14d. Oxidation at elevated temperatures (+50˚C) can be 
problematic because of the undesired chemical noise and oxidation products. Containing 
the performic acid vapor at elevated temperatures and pressures can be difficult without 
the proper reaction vessel to prevent the vapor from escaping the chamber. In the +50˚C 
oxidation experiment, the oxidation time was ca. 10-20 min owing to the performic acid 
vapor escaping the reaction chamber. At this point, oxidation at +25˚C seems suitable to 
oxidize these standard peptides with minimal oxidation side products for α-MSH. The 
increased oxidation temperature may become important to successfully oxidize difficult-
to-oxidize disulfide-containing peptides and/or proteins (e.g., intact bovine insulin).  
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Figure 14. Effect of on-target oxidation temperature on the resulting oxidation products 
from a mixture of standard peptides. The standard peptides labeled are as follows: (A) 
Arg8-Vasopressin (CYFQNCPRG-NH2), (B) α-melanocyte stimulating hormone (Ac-
SYSMEHFRWGKPV-NH2), and (C) Cys8-renin (DRVYIHPCHLLYYS). Negative ion 
mass spectra are shown (a) before and after on-target oxidation at (b) -20˚C, (c) +25˚C, 
and (d) +50˚C using CHCA as the MALDI matrix during oxidation.  
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Performic Acid Exposure Time 
 Initial on-target oxidation experiments were performed using an hour of 
oxidation because traditional solution-phase oxidation methods use similar oxidation 
times.46 An on-target oxidation time course from 0-60 min was carried out using Arg8-
vasopressin (CYFQNCPRG-NH2), α-melanocyte stimulating hormone (Ac-
SYSMEHFRWGKPV-NH2), and Cys8-renin (DRVYIHPCHLLYYS) denoted as A, B, 
and C, respectively.  
Figure 15 contains the negative ion mass spectra (a) before and after on-target 
oxidation performed for (b) 5 min and (c) 15 min at room temperature (+25˚C) using 
CHCA as the MALDI matrix during oxidation. Note that oxidized Cys8-renin [C – H + 
O3]- is present prior to oxidation (Figure 15a). Following oxidation the relative 
abundance of the oxidized Cys8-renin [C – H + O3]- ion at m/z 1824.98 increases 
drastically after 5 min of oxidation (Figure 15b). Oxidized Arg8-vasopressin [A – H + 
O6]- is also readily observed at m/z 1180.50 in the negative ion mass spectrum after 5 
min of oxidation. After 15 min of oxidation (Figure 15c), the relative abundance of both 
Arg8-vasopressin and Cys8-renin increase compared to oxidation for only 5 min. Overall, 
it appears the improved ion signal for the oxidized products from 0-15 min indicates the 
oxidation time can improve the oxidized peptide ion yield. However, as the oxidation 
time increases from 15-60 min the oxidized peptide ion yield appears not to improve in 
terms of the relative abundance increasing over time. Another possible explanation is the 
peptide molecules on the surface of the MALDI matrix crystal are becoming readily 
oxidized while those peptide molecules co-crystallized within the matrix are inaccessible 
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to the performic acid vapor. Therefore, we must investigate the effect of the MALDI 
matrix (crystal lattice) on the resulting oxidized peptide ion yield. 
 
Alternative MALDI Matrices for On-Target Oxidation 
Initial difficulty completely oxidizing insulin α-chain motivated further 
investigation of alternative MALDI matrices used for on-target oxidation. Nine different 
MALDI matrices and a dual matrix with 2,4-DHAP combined with CHCA were used to 
investigate the effect of the MALDI matrix on the oxidized peptide ion yield (Table 2). 
The oxidized insulin α- and β-chains are monitored in terms of being observed (+) and 
not observed (-) in the positive and negative ion mass spectra. Take notice that only 2,4-
DHAP and CHCA have oxidized peptide ion signals present. Figure 16 contains 
negative ion mass spectra of intact insulin after on-target oxidation using (a) CHCA, (b) 
2,4-DHAP, and (c) 2,4-DHAP used during oxidation followed by an overlayer of 
CHCA. Note that ion signals corresponding to fully oxidized insulin α-chain are not 
present when using CHCA during oxidation. However, when 2,4-DHAP is used 
throughout oxidation the fully oxidized insulin α-chain (m/z 2528.61 for [α – H + O12]-) 
is observed in the negative ion mass spectrum at S/N 66 (Figure 16b). Enhanced 
negative ion yields are observed for oxidized insulin α-chain when CHCA is added as an 
overlayer to 2,4-DHAP. For example, the [α – H + O12]- ion signal improves ca. 2.8-fold 
when using the dual matrix approach compared to using 2,4-DHAP alone. 
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Figure 15. Selected negative ion mass spectra from the oxidation time course designed 
to evaluate the effect of performic acid vapor exposure time on the oxidation of a 
standard peptide mixture. On-target oxidation performed for (a) 0 minutes, (b) 5 
minutes, and (c) 15 minutes are shown. The standard peptides are denoted in the mass 
spectra as follows: (A) Arg8-Vasopressin (CYFQNCPRG-NH2), (B) α-melanocyte 
stimulating hormone (Ac-SYSMEHFRWGKPV-NH2), and (C) Cys8-renin 
(DRVYIHPCHLLYYS). Oxidation for these experiments was performed at +25˚C using 
CHCA as the MALDI matrix during oxidation.  
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For comparative purposes, each MALDI sample deposit shown in Table 2 
received an overlayer of CHCA following oxidation. The dual MALDI matrix may 
improve the negative ion yield of the oxidized peptides on the MALDI sample deposit. 
Several MALDI matrices now have detectable ion signals present for the insulin α- and 
β-chains. Only two methods, 2,4-DHAP and ferulic acid combined with CHCA as dual 
MALDI matrices, have detectable ion signals for the fully oxidized insulin α-chain [α – 
H + O12]- at m/z 2528.64. Abundant signal for fully oxidized insulin β-chain [β – H + 
O6]- ion at m/z 3492.88 is observed in each method with the exception of sinapic acid in 
which lacks oxidized peptide ion signals. The remainder of the matrices (e.g., 3,5-
DMHCA, 4-HPCA, and 2,6-DHAP) have an enhanced negative ion signal for partially 
oxidized insulin α-chain (m/z 2463.13). It appears that partially oxidized insulin α-chain 
is the predominant oxidation product when starting with intact insulin. A portion of the 
insulin α-chain amino acid sequence was confirmed by tandem MS; however, the lack of 
sequence informative fragment ions below m/z 800 prevents complete sequence 
determination (data not shown). Overall, it appears that only 2,4-DHAP successfully 
oxidizes both the insulin α- and β-chains. These select MALDI matrices were then used 
to oxidize Cys-kemptide (CLRRASLG) to further understand the improved oxidation 
with an alternative matrix. 
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Table 2. Summary of On-Target Performic Acid Oxidation of Intact of Insulin 
using Varied MALDI Matrices 
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Figure 16. Typical negative ion mass spectra resulting from on-target oxidation of intact 
bovine insulin using (a) α-cyano-4-hydroxycinnamic acid, (b) 2,4-
dihydroxyacetophenone and (c) 2,4-DHAP used during oxidation followed by an 
overlayer of CHCA. The on-target oxidation was performed at room temperature 
(+23˚C) for 60 minutes prior to mass spectrometry analysis. 
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Initial experiments designed to evaluate several MALDI matrices for on-target 
oxidation were performed with oxytocin (CYIQNCPLG-NH2) as the model oxidizable 
analyte. The majority of the MALDI matrices used for on-target oxidation were 
successful in forming fully oxidized oxytocin [M – H + O6]- ions in the negative ion 
mass spectra (See Table 3). The initial MALDI matrix list of ten was narrowed down to 
five matrices to further evaluate the effect of the matrix on the resulting ion yield of 
oxidized product. Specifically, on-target oxidation with (a) 2,4-dihydroxyacetophenone 
(2,4-DHAP), (b) 2,5-dihydroxybenzoic acid (2,5-DHB), (c) 4-hydroxy-α-
phenylcinnamic acid (4-HPCA), (d) α-cyano-4-hydroxycinnamic acid (CHCA), and (e) 
3,5-dimethyl-4-hydroxycinnamic acid (3,5-DMHCA) are shown (See Scheme 2). 
An evaluation of the oxidized peptide ion yield for each MALDI matrix (a-e) is 
presented in Figure 17a for Cys-kemptide. The average signal-to-noise ratios for native 
cys-kemptide [M – H]- ions and fully oxidized cys-kemptide [M – H + O3]- ions are 
compared for oxidized peptides formed via on-target oxidation performed in triplicate 
(average of nine MALDI spots was used for statistical evaluation). Note that oxidized 
Cys-kemptide [M – H + O3]- ions are observed for each MALDI matrix 
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Table 3. Summary of On-Target Oxidation of Oxytocin (CYIQNCPLG-NH2) using 
various MALDI Matrices  
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Scheme 2. Images (60X magnification) of typical MALDI sample deposits of (a) 2,4-
dihydroxyacetophenone, (b) 2,5-dihydroxybenzoic acid, (c) 4-hydroxy-α-
phenylcinnamic acid, (d) α-cyano-4-hydroxycinnamic acid, and (e) 3,5-dimethyl-4-
hydroxycinnamic acid co-deposited with analyte. Their corresponding chemical 
structure is found below each MALDI spot image. 
 
     
 
 
with the exception of 2,5-DHB. However, a low abundance of oxidized Cys-kemptide is 
observed for 2,5-DHB in the positive ion mass spectrum (data not shown). We suspect 
that 2,5-DHB either suffers from ion suppression effects from the performic acid vapor 
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or becomes oxidized to the hydroquinone form then functions poorly as a MALDI 
matrix, similar as previously reported.109 Additionally, the hydroquinone form of 2,5-
DHB appears to be reacting with the free thiol of Cys-kemptide during the MALDI 
process, similar as reported by Qiao and coworkers.110 Therefore, 2,5-DHB is not 
suitable for on-target oxidation of free cysteine-containing peptides.  A high relative 
abundance of oxidized Cys-kemptide [M – H + O3]- ions are observed when using 4-
HPCA and CHCA during oxidation. Note that a similar abundance of native Cys-
kemptide [M – H]- ions are remaining after oxidation for both 4-HPCA and CHCA. It 
also appears that cysteic acid-containing peptides are more readily ionized when using 
2,4-DHAP and 3,5-DMHCA. Additionally, non-oxidized peptide ion signals for Cys-
kemptide [M – H]- ions remain after on-target oxidation for each MALDI matrix except 
2,4-DHAP and 3,5-DMHCA. However, the decreased oxidized ion yield for these 
matrices suggests that non-oxidized peptide molecules are not being successfully ionized 
owing to poor ionization efficiency of the MALDI matrix to produce negative ions. To 
further probe the non-oxidized peptide molecules on these sample deposits we added an 
overlayer of CHCA to enhance the negative ion yield of the [M – H]- ion. 
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Figure 17. Graphical depiction of the signal-to-noise comparison for each MALDI 
matrix used for on-target oxidation of Cys-kemptide (CLRRASLG) (a) Summary of 
negative ion mass spectrometry data using varied MALDI matrices (a-e) for on-target 
oxidation of Cys-kemptide. Panel (b) represents the negative ion mass spectral data for 
Cys-kemptide oxidized in the presence of varied MALDI matrices with an overlayer of 
CHCA added prior to mass spectrometry analysis.  
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Figure 18. Graphical depiction of the signal-to-noise comparison for each MALDI 
matrix used for on-target oxidation of Cys-kemptide (CLRRASLG) (a) Summary of 
positive ion mass spectrometry data using varied MALDI matrices (a-e) for on-target 
oxidation of Cys-kemptide. Panel (b) represents the positive ion mass spectral data for 
Cys-kemptide oxidized in the presence of varied MALDI matrices with an overlayer of 
CHCA added prior to mass spectrometry analysis.  
 
  82   
Figure 17b contains the graphical evaluation of each MALDI matrix (a-e) 
combined with CHCA applied after on-target oxidation of Cys-kemptide. These MALDI 
spots were oxidized in parallel with the data presented in Figure 17a with the exception 
of the dual MALDI matrix prior to mass spectrometry analysis. The abundance of the [M 
– H + O3]- ion drastically increases for each MALDI matrix with the exception of 2,5-
DHB. Oxidized Cys-kemptide formed in the presence of 4-HPCA has the most abundant 
oxidized ion signal when compared to the other matrices. However, native Cys-kemptide 
[M – H]- are observed after oxidation which suggests the oxidation is incomplete. Note 
that native Cys-kemptide [M – H]- ions are not observed in Figure 17a or 17b for 2,4-
DHAP which suggests that the oxidation has gone to completion. Additionally, native 
Cys-kemptide [M + H]+ ions are not observed in the positive ion mass spectrum for 
either 2,4-DHAP or the 2,4-DHAP + CHCA dual MALDI matrix (See Figure 18). 
Interestingly, the abundance of native Cys-kemptide is low for both CHCA and 3,5-
DMHCA. The native Cys-kemptide abundance is ca. 2500 S/N when CHCA is used 
without CHCA re-deposition (Figure 17a). We suspect that additional oxidation 
chemistry is occurring with the residual performic acid on the CHCA matrix crystalline 
surface to result in enhancement of oxidized product yield. To probe this hypothesis, we 
oxidized a deposit of CHCA without analyte then added second deposit containing a 
mixture of CHCA combined with Cys-kemptide and a very low abundance of oxidized 
peptide is observed in the negative ion mass spectrum (data not shown). This control 
experiment suggests that additional oxidation does not occur when a CHCA overlayer is 
applied to an oxidized sample deposit. It is also important to note that oxidation does 
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occur when the analyte is deposited directly on the stainless steel MALDI target without 
matrix. Additionally, on-target oxidation occurs when Cys-kemptide is co-crystallized 
with MALDI inactive crystalline solids such as fructose and 4-phenylbutyric acid (4-
PBA). However, the abundance of the oxidized Cys-kemptide [M – H + O3]- ion is the 
greatest when using CHCA during oxidation as opposed to fructose and 4-PBA used 
during oxidation (See Figure 19). 
 
Figure 19. Comparison of the resulting oxidized peptide ion yield using various 
crystalline solids used for on-target oxidation of Cys-kemptide (error bars represent an 
average of three oxidized MALDI spots). For each crystalline solid, the analyte was 
deposited as an overlayer to pre-spotted fructose, 4-phenylbuytric acid, and CHCA. This 
particular on-target oxidation was performed at 25˚C for 15 min. 
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On-Target Oxidation and Subsequent Proteolytic Digestion of Intact Proteins 
 In a previous manuscript we demonstrated the ability to elucidate disulfide linked 
peptides from Ribonuclease A (RNase A) proteolytic digest using the combined positive 
and negative ion mass spectra following on-target oxidation.48 Disulfide bonds within 
proteins (e.g., bovine pancreatic trypsin inhibitor) are known to prevent complete 
proteolytic digestion owing to inaccessible proteolytic cleavage sites which results in 
inefficient protein digestion. Several research groups have successfully employed on-
target proteolytic digestion techniques to various tissue sections for imaging mass 
spectrometry experiments.108, 111 On-target oxidation of an intact protein would cleave 
the native disulfide bond pattern leaving the protein accessible to proteolytic digestion. 
Herein, we demonstrate an alternative protein digestion scheme using two on-target 
methods to oxidize/digest bovine pancreatic trypsin inhibitor (BPTI) and bovine RNase 
A. 
 
Scheme 3. Experimental scheme for on-target oxidation of intact disulfide-
containing proteins followed by subsequent on-target proteolytic digestion and 
MALDI-MS analysis. 
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The experimental scheme for the on-target oxidation and subsequent proteolytic 
digestion of an intact disulfide-containing protein is shown in Scheme 3. First, the intact 
protein is co-crystallized with the MALDI matrix then oxidized using the on-target 
oxidation method. Second, the oxidized protein is digested using a protease (e.g., 
trypsin) in the presence of MALDI matrix then subjected to MS analysis. BPTI is an 
excellent model disulfide-containing protein to illustrate the ability to both oxidize and 
digest proteins on the MALDI target. BPTI contains three disulfide bonds and several 
trypsin cleavage sites as shown in Scheme 4.    
 
Scheme 4. Amino acid sequence of bovine pancreatic trypsin inhibitor shown with 
its native disulfide-bonds (Cys5- Cys55, Cys14- Cys38, Cys30- Cys51). The trypsin 
cleavage sites are denoted in bold italics. 
 
 
 
 Figure 20a contains the negative ion mass spectrum of BPTI oxidized and 
digested with trypsin on the MALDI target. Note that both the oxidation (10 min) and 
proteolytic digestion (60 min) were performed in the presence of 2,4-DHAP MALDI 
matrix. CHCA was added after oxidation and digestion to enhance the negative ion 
yields. Several oxidized peptides labeled (A-I) are observed in the negative ion mass 
spectrum after oxidation and digestion (Figure 20b). The amino acid sequence coverage 
for this small protein is 100% with all six cysteine residues involved in disulfide 
bridging detected in their oxidized form. For example, the oxidized BPTI peptide 
27AGLCoxQTFVYGGCoxR39 (m/z 1468.62) is observed with two cysteic acid groups 
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because it lacks trypsin cleavage sites in this region of the protein. In the control 
experiment without oxidation, proteolytic peptides are not observed in the negative ion 
mass spectrum (data not shown). Hence, the oxidation breaks each disulfide bond 
converting each cysteine residue to cysteic acid which improves the accessibility of the 
protease to cleave after proteolytic cleavage sites. This on-target oxidation followed by 
on-target proteolytic digestion has also been applied to bovine Ribonuclease A which 
contains one intra- and three inter-linked disulfide bonds. RNase A oxidized peptides are 
readily observed after only 5 min of oxidation followed by proteolytic digestion (See 
Figure 21a). The oxidized RNase A peptides account for 70% of the amino acid 
sequence with four oxidized cysteine residues. The missing portion of the RNase A 
sequence is suspected to be either inaccessible to the performic acid vapor or the 
protease to successfully cleave this protein section. Overall, this on-target oxidation and 
subsequent proteolytic digestion protocol could be applied to tissue sections which are 
profiled using imaging mass spectrometry. The on-target oxidation will rapidly improve 
the protease accessibility to successfully digest difficult-to-digest proteins within tissue 
sections. 
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Figure 20. (a) Representative negative ion mass spectrum for on-target oxidation and 
digestion of bovine pancreatic trypsin inhibitor (BPTI). The on-target oxidation was 
performed for 10 min for this example at room temperature (+23˚C) followed by on-
target trypsin digestion for 60 min. (b) Summary of the BPTI oxidized peptides (A-I) 
identified based on accurate mass measurement. 
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Figure 21. (a) Representative negative ion mass spectrum for on-target oxidation and 
digestion of bovine Ribonuclease A (RNase A). The on-target oxidation was performed 
for 5 min for this example at room temperature (+23˚C) followed by on-target trypsin 
digestion for 60 min. (b) Summary of the RNase A oxidized peptides (A-H) identified 
based on accurate mass measurement. 
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Conclusion 
The experimental variables associated with the on-target oxidation method were 
evaluated using several model cysteine and/or disulfide-containing peptides and 
proteins. Overall, the elevated temperature oxidation (+25˚C) does not have a 
detrimental effect on peptides that contain histidine, tryptophan, or tyrosine amino acid 
residues when CHCA is used during oxidation. Cysteine oxidation can be achieved in 
only 5 minutes with optimal oxidation in 15 min for small cysteine-containing peptides. 
Intact insulin requires increased oxidation (60 min) and an alternative MALDI matrix 
(2,4-DHAP) in order achieve complete oxidation of the insulin α and β-chains. An 
improved oxidized product yield is observed for oxidized Cys-kemptide (CoxLRRASLG) 
when using 2,4-dihydroxyacetophenone or 3,5-dimethyl-4-hydroxycinnamic acid as the 
MALDI matrix during oxidation. In addition, on-target oxidation of a disulfide-
containing protein followed by on-target proteolytic digestion was demonstrated for 
bovine pancreatic trypsin inhibitor, thus improving the digestion efficiency of a difficult-
to-digest protein. Future experiments involve the investigation of the negative ion 
fragmentation of these cysteic acid-containing peptides. 
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CHAPTER V 
EFFECT OF CYSTEIC ACID POSITION ON NEGATIVE ION 
FRAGMENTATION OF RIBONUCLEASE A PROTEOLYTIC PEPTIDES 
 
Introduction 
The vast majority of proteomics studies utilize positive ion data for single and 
multiple stages of mass spectrometry for protein and peptide identification. However, 
negative ion mass spectrometry provides a specific utility towards the detection and 
identification of peptide/protein post-translational modifications (e.g., glycosylation, 
sulfation, and phosphorylation).112, 113 The fragment ion spectra of peptide [M – H]- ions 
provides information not commonly afforded by positive ion tandem mass 
spectrometry.112, 113 For example, tandem MS precursor ion scanning techniques have 
enabled the selective detection of phosphopeptides from a complex mixture owing to the 
diagnostic loss of m/z 79 (PO3-) or m/z 97 (H2PO4-) from the parent [M – H]- ion.114-116 
Additionally, several side chain loss fragment ions (e.g., Asp, Gln, Ser, Thr, and Cys) 
are frequently observed using either positive or negative ion tandem MS which can 
enable differentiation between glutamine and lysine, two near isobaric amino acid 
residues.112 The backbone cleavage products of [M – H]- peptide ions are somewhat 
similar to positive ion fragment ions; however, the mechanism of fragment ion formation 
is quite different. Bowie and coworkers have developed negative ion fragmentation 
nomenclature to describe these processes.112, 113, 117  For example, backbone cleavages of 
the peptide amide bond are called α- and β-fragmentations which are somewhat similar 
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to y-type and b-type fragment ions in positive ion nomenclature, respectively (See 
Scheme 5). 
 
 
Scheme 5. Generic structures of αn and βn fragment ions according to nomenclature 
and fragmentation mechanisms described by Bowie and coworkers.112 
 
 
 
Cysteic acid-containing peptide ions are known to yield abundant fragment ions 
involving the loss of the cysteic acid side chain.118, 119 For example, Gaskell and 
coworkers have reported d-type fragment ions for oxidized RLAIFCoxFR.119 
Specifically, a d7 (partial side-chain loss of –SO3H) fragment ion is observed in the 
fragment ion mass spectrum of the [M + 2H]2+ ion of the oxidized peptide. However, 
when the cysteic acid position changes for the oxidized peptide RLCoxIFSAFR a d3 
fragment ion is observed in the positive ion tandem mass spectrum. The cysteic acid is 
suspected to be involved in the d-type fragment ion formation mechanism through the 
interaction with the N-terminal arginine side chain. In earlier work by Gaskell et al. they 
investigated the positive ion fragmentation of a cysteic acid-containing peptide 
  92   
(CoxGQPLQNK) with the cysteic acid at the N-terminus.45 The positive ion tandem mass 
spectrum is dominated by a y-type fragment ion series owing to positive charge 
localization at the C-terminal lysine. They conclude that the cysteic acid promotes 
interaction with the lysine and arginine residues at the C-terminus and allows the 
“mobile proton” to move freely along the peptide backbone.118-120  
Here we investigate the effect of cysteic acid position on the negative ion 
fragmentation of RNase A proteolytic derived peptides. Distinct d-type fragment ion 
series are observed from peptides that contain an N-terminal cysteic acid. Our main 
hypothesis states as the cysteic acid position changes we suspect that the side-chain 
fragment ion type will change, i.e., form v- and w-type fragment ions as the cysteic acid 
moves towards to the C-terminus. To evaluate the effect of the cysteic acid position on 
partial and full-side chain loss fragment ion formation we chose to study RNase A 
proteolytic peptides with the cysteic acid at the N-terminus, near the center of the 
peptide, and toward the C-terminus. Additional studies were performed on native Cys-
kemptide (CLRRASLG) and oxidized Cys-kemptide (CoxLRRASLG), a model peptide 
with cleavable side chains and an N-terminal cysteic acid after on-target performic acid 
oxidation. 
 
Experimental 
Chemicals 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless 
otherwise noted. Hydrogen peroxide (35% w/w) and formic acid (99% w/w) were 
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purchased from Acros Organics (Morris Plains, NJ). HPLC grade acetone and methanol 
(CH3OH) were purchased from EMD Chemicals Inc. (Gibbstown, NJ). All experiments 
were performed with 18-MΩ water (ddH2O) purified using a water purification unit 
(Barnstead International, Dubuque, IA).   
 
Sample Preparation for MALDI-MS 
A stock solution of Cys-kemptide (CLRRASLG) was prepared at 10 µM in 10 
mM formic acid. The peptide solution was mixed 1:1 with CH3OH and 1 µL was spotted 
as an overlayer to pre-spotted CHCA matrix. CHCA was prepared at 5 mg mL-1 in a 2:3 
ddH2O: CH3OH solution containing 10 mM NH4H2PO4 and 1 µL was pre-spotted as the 
underlayer.90 This cysteine-containing peptide was later oxidized using the on-target 
oxidation procedures described below. 
 
Ribonuclease A Proteolytic Digestion 
Dual protease digestion (trypsin followed by chymotrypsin) of RNase A was 
performed using previously described methods.48, 56Briefly, RNase A was dissolved at 1 
mg mL-1 in a 25 mM ammonium acetate buffer adjusted to pH 6.0 with 10 mM formic 
acid. RNase A was digested with and without chemical reduction of the disulfide bonds. 
For the non-reduced digest, RNase A was initially digested with trypsin (1:50 enzyme: 
protein ratio) for 4 hrs at 37˚C followed by chymotrypsin addition (1:50 enzyme: protein 
ratio) and incubation for an additional 4 hrs. For the reduced RNase A digest, the sample 
solution was subjected to TCEP reduction (2 µL of 50 mM TCEP prepared in ddH2O) 
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by incubating at 60˚C for 60 min. Following TCEP reduction, the protein was digested 
with trypsin followed by chymotrypsin using the same procedure as the non-reduced 
digest. Following proteolytic digestion, the sample was subjected to cleanup using a 10 
µL C18 resin pipette tip. The RNase A proteolytic digest was eluted with a 60:40 
CH3CN: ddH2O solution containing 0.1% formic acid and 1 µL was spotted as the 
overlayer to CHCA matrix.  
 
On-Target Performic Acid Oxidation 
 On-target oxidation was performed as described previously.48 Briefly, 40 µL of a 
1:1 mixture of acetone: performic acid was placed directly on the MALDI target in a 
region that does not contain sample. The MALDI target was then covered in a plastic 
petri dish and was allowed to react at room temperature (+24˚C) for 10-60 min. 
Following on-target performic acid oxidation the MALDI plate is then subjected to 
MALDI analysis without sample cleanup.  
 
4-Sulfophenyl Isothiocyanate Derivatization of Cys-Kemptide 
Stock solutions of Cys-kemptide were prepared at 10 µM in 20 mM tetraethyl 
ammonium bicarbonate. The Cys-kemptide solution was first reduced with TCEP at 
60˚C for 60 min. Followed by 2-iodoacetamide alkylation by incubating for 45 min at 
room temperature in the dark. The SPITC derivatization was performed using previously 
described methods with minor modifications.121 Briefly, the SPTIC derivatization was 
performed in tetraethyl ammonium bicarbonate at 1000-fold molar excess of SPITC: 
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peptide using 55˚C reaction temperatures for 30 min. Following SPTIC derivatization, 
samples were subjected to cleanup using a 10 µL C18 resin pipette tip. The alkylated 
Cys-kemptide + SPITC reaction mixture was eluted with a 60:40 CH3CN: ddH2O 
solution containing 0.1% formic acid and 1 µL was spotted as the overlayer to CHCA 
matrix.  
 
MALDI-MS and MALDI-MS/MS 
All MALDI-MS experiments were performed using a model 4700 Proteomics 
Analyzer MALDI-TOF/TOF (Applied Biosystems, Framingham, MA). The MALDI-MS 
data were acquired using the reflectron detector in both positive and negative ion modes 
using 1200 laser shots with external calibration using bradykinin (2-9) (PPGFSPFR) and 
ACTH (18-39) (RPVKVYPNGAENESAEAFPLEF). Positive and negative ion 
collision-induced dissociation (CID) tandem MS spectra were acquired using 20% 
greater laser power than the MS spectra acquisition with atmosphere (medium pressure) 
as the collision gas with 1 kV of collision energy. 
The peptide fragmentation nomenclature developed by Roepstorrff122 and 
modified by Biemann123 was used to describe the side-chain loss fragment ions that we 
observe in the negative ion tandem mass spectra. In regards to the negative ion peptide 
fragmentation nomenclature developed by Bowie and coworkers, several different side-
chain losses are observed in the negative ion tandem mass spectra of [M – H]- peptide 
ions;112 however, nomenclature to describe the site of bond cleavage and the type (partial 
or full) of side-chain loss has not yet been clearly defined. Hence, our rationale to use 
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positive ion peptide fragmentation nomenclature to describe the side-chain loss fragment 
ions observed within. 
 
Results and Discussion 
Positive and Negative Ion Fragmentation of Native and Oxidized Cys-Kemptide 
Figure 22 contains positive and negative ion fragmentation data for Cys-
kemptide (CLRRASLG) before and after on-target performic acid oxidation. The y5 ion 
in the positive ion tandem mass spectrum (Figure 22a) is the most abundant 
fragmentation channel with several partial side-chain cleavage ions present. The peptide 
fragmentation nomenclature for side-chain loss fragment ions (dn, vn, and wn) are 
illustrated in Scheme 6 for deprotonated peptide ions. Note that a d4 fragment ion is 
observed at m/z 416.27 corresponding to backbone cleavage at the a4 position with a 
partial arginine side chain loss (cleavage between the β and γ carbon atoms) and the 
overall charge is retained toward the N-terminus of the peptide. Additional d-type 
fragment ions are observed (d6 and d7) corresponding to the partial side chain losses of 
serine and leucine, respectively. It appears that the localization of the positive charge by 
the two arginine side chains is causing the somewhat fixed positive charge near the N-
terminus to form partial side-chain cleavage fragment ions. As the positive charge carrier 
moves along the peptide backbone the probability of forming w-type fragment ions 
increases. In Figure 22a, abundant ion signals for w6 and w7 fragment ions are observed 
which correspond to z-type backbone cleavage with partial side-chain loss of arginine 
and leucine, respectively. However, the w5 fragment ion formation is not favorable, 
owing to the lack of a positive charge carrier in the resulting fragment ion. As for the 
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positive ion tandem mass spectrum of oxidized Cys-kemptide (CoxLRRASLG) [M + H + 
O3]+ ion results in several y-type fragment ions and the loss of 17 Da (NH2) from the y6 
and y7 ions which is most likely coming from the guanidino group of arginine (Figure 
22b). Note that side-chain loss fragment ions (i.e., w- and d-type fragment ions) are also 
observed, similar to the fragment ion spectrum of native Cys-kemptide [M + H]+ ion. 
 
 
 
Figure 22. (a) Positive and (c) negative ion tandem mass spectra of native Cys-kemptide 
(CLRRASLG). (b) Positive and (d) negative ion tandem mass spectra of oxidized Cys-
kemptide (CoxLRRASLG).  
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Scheme 6. Generic peptide amino acid sequence with the γ carbon atom denoted 
with R1-R5. Structures of dn, vn, and wn fragment ions are denoted below each 
arrow. 
 
 
For comparison, the negative ion tandem mass spectrum for native Cys-kemptide 
[M – H]- ions is shown in Figure 22c. This spectrum contains a near complete series of 
y-type fragment ions. Also, note that a dominant c5 fragment ion (m/z 615.56) is also 
present in Figure 22c. Conversely, the negative ion spectra of oxidized Cys-kemptide 
(CoxLRRASLG) is composed of very different fragment ions because the cysteic acid 
group induces a fixed negative charge at the N-terminus of the peptide, which results in 
near complete d-type fragment ion series (Figure 22d). Note that the d5 fragment ion is 
not observed because the alanine side chain does not have a cleavable β-γ carbon-carbon 
bond. It is important to note that side-chain loss fragment ions are not observed in the 
negative ion mass spectrum without CID collision gas (2.8 x 10-8 torr), thus the 
additional collisions at higher pressure (9.0 x 10-7 torr) are required to form the d-type 
fragment ions (See Figure 23). 
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Figure 23. Negative ion tandem mass spectra of the oxidized Cys-kemptide [M – H + 
O3]- ion fragmented (a) without additional collision gas (2.8E-8 torr) and (b) with 
collision gas set at medium pressure (9.0E-7 torr). 
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To further investigate the role of the fixed N-terminal negative charge in the 
formation of d-type fragment ions, we chose to perform N-terminal 4-sulfophenyl 
isothiocyanate (SPITC) derivatization of Cys-kemptide. SPITC is a commonly used in 
de novo peptide sequencing as a derivatization reagent to place a fixed negative charge 
at N-terminus of the peptide which results in primarily y-type fragment ion series.121, 124 
The free thiol group of Cys-kemptide was alkylated with 2-iodoactamide prior to SPITC 
derivatization owing to the loss of 34 Da (H2S) during SPITC derivatization of native 
Cys-kemptide. Two d-type fragment ions are observed (d1 and d2) in the negative ion 
tandem mass spectrum of alkylated Cys-kemptide + SPITC at 1145.59 m/z (See Figure 
24). There are only a few d-type fragment ions because the facile loss of the SPITC 
group during collisional activation limits the number of fragmentation channels. The 
cysteic acid group of oxidized Cys-kemptide stays intact after collisional activation; 
therefore, the near-complete series of d-type fragment ions are observed (Figure 22d). 
Therefore, we suspect that the negative charge localization at the N-terminus promotes 
d-type ion formation.  
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Figure 24. Negative ion tandem mass spectrum of alkylated Cys-kemptide + SPITC at 
m/z 1145.59. Inset: expanded view of mass range 240-440 m/z illustrating that two d-
type fragment ions d1 and d2 are present. 
 
RNase A Proteolytic Peptides: N-terminal Cysteic Acid 
The results described above suggest that the cysteic acid position plays a role in 
d-type fragment ion formation; and to probe this further we investigated several RNase 
A proteolytic peptides that have the cysteic acid at the N-terminus, center, and toward 
the C-terminus of the peptide. These RNase A proteolytic peptides were produced from 
a dual enzyme digestion using trypsin followed by chymotrypsin. The negative ion 
tandem mass spectra of three oxidized RNase A proteolytic peptides that have N-
terminal cysteic acid are contained in Figure 25. Several d-type fragment ions (d2-d4) are 
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observed for 52CoxNQMM56 in Figure 25a. The d5 fragment ion is present at low relative 
abundance at m/z 598.24. Note that methionine residues are also oxidized (denoted in 
bold italics) by using the on-target oxidation method. Similar d-type fragment ions are 
observed for 52CoxNQMMK57 which contains a C-terminal lysine residue, and a more 
abundant d5 fragment ion formed by side-chain cleavage of the oxidized methionine 
residue is observed (Figure 25b). When the cysteic acid is adjacent to a lysine residue d-
type fragment ions are still formed. For example, [M – H + O3]- ions of 66CoxKPVNTF72 
form abundant d2, d4, and d5 fragment ions (Figure 25c). We also observe an ion signal 
at 645.52 m/z which could correspond to the a6-17 ion or the db6 ion for the loss of the 
hydroxyl group (-OH) from the threonine residue. The d3 ion for 66CoxKPVNTF72 is 
absent because cyclic amino acids (proline) do not produce d-type fragment ions.123 
Collectively, the data suggests that peptides containing cysteic acid favor formation of d-
type fragment ions under two conditions: the cysteic acid (fixed negative charge) is at 
the N-terminus and the amino acid side chain has a cleavable β-γ carbon-carbon bond. 
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For comparison, the CID spectra of model peptides containing N-terminal 
aspartic acid or glutamic acid were also examined. Angiotensin I (DRVYIHPFHL) 
which has N-terminal aspartic acid yields abundant y-type fragment ions (y1, y2, y4, y6, 
y7, and y9) and no d-type fragment ions (Figure 26). Conversely, several d-type fragment 
ions (d3, d5, d10) are observed in the positive ion tandem mass spectrum owing to the 
charge-carrying arginine side chain located near the N-terminus of the peptide. The N-
terminal glutamic acid-containing peptide Glu-Fibrinopeptide B 
(EGVNDNEEGFFSAR) fragments to form both b- and y-type fragment ions and a low 
abundance w8 fragment ion (See Figure 27). Gaskell and coworkers performed similar 
experiments on aspartic and glutamic acid analogues of RLAIFSCoxFR.118 Specifically, 
they investigated RLEIFSEFR and RLDIFSDFR, where the positive ion fragmentation 
of RLDIFSDFR [M + 2H]+2 ions results in d3 and d7 whereas for RLEIFSEFR these two 
d-type fragment ions are not observed. The aspartic acid side chain (-CH2COOH) and 
the cysteic acid side chain (-CH2SO3H) both contain a single methylene group (i.e., d-
type fragment ions are formed under similar pathways); whereas the glutamic acid side 
chain has an additional methylene spacer which prevents d-type ion formation.  
 
 
 
 
  104   
 
 
Figure 25. Typical negative ion tandem mass spectra for oxidized RNase A proteolytic 
peptides where the cysteic acid is at the N-terminus of the peptide. (a) 52CoxNQMM56, 
(b) 52CoxNQMMK57, and (c) 66CoxKPVNTF72. 
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Figure 26. Negative ion tandem mass spectrum for the standard peptide Angiotensin I 
(DRVYIHPFHL). 
 
 
 
 
Figure 27. Negative ion tandem mass spectrum for the standard peptide Glu-
Fibrinopeptide B (EGVNDNEEGFFSAR). 
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RNase A Proteolytic Peptides: Cysteic Acid Near the Peptide Center 
 RNase A proteolytic peptides with the cysteic acid towards the center of the 
peptide were also examined. [M – H]- ions of 82AVCoxSQK87 yield two d-type fragment 
ions (d4 and d5) by partial side chain loss of serine and glutamine, respectively (Figure 
28a). For 118YPNCoxAY123 (Figure 28b), d-type fragment ions are not observed because 
the alanine side chain lacks a cleavable β-γ carbon-carbon bond and side chain cleavage 
of an aromatic side chain (tyrosine) is not favorable.123 However, a w-type fragment ion 
is observed at the w4 position for the side chain loss of asparagine with the negative 
charge retained toward the C-terminus of the peptide. It appears that d-type ion 
formation is possible for the amino acid side chains C-terminal to the cysteic acid. This 
is the case for 131HIIVACoxEGNPY141 which yields two d-type fragment ions, d7 and d9 
corresponding to side chain loss of glutamic acid and asparagine, respectively (Figure 
28c). Interestingly, a w5 ion is observed in the negative ion tandem mass spectrum for 
native 131HIIVACEGNPY141 corresponding to the partial side chain loss of glutamic acid 
(See Figure 29). Similar side chain losses were previously reported for [M – H]- ions for 
underivatized peptides.125 The observation of w-type ions is interesting; because this 
result supports our main hypothesis; i.e., the side-chain fragment ion type will change to 
v- or w-type ions as the cysteic acid moves toward the C-terminus. 
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Figure 28. Typical negative ion tandem mass spectra for oxidized RNase A proteolytic 
peptides that have the cysteic acid side chain near the center of the peptide. (a) 
82AVCoxSQK87, (b) 118YPNCoxAY123, and (c) 131HIIVACoxEGNPY141. Inset figure: 
expanded view of mass range 720-740 m/z illustrating that two fragment ions d7 and y6 
are present. 
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Figure 29. Negative ion tandem mass spectrum for the native RNase A peptide 
131HIIVACEGNPY141. 
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RNase A Proteolytic Peptides: Cysteic Acid Toward the C-terminus 
 Figure 30 contains the negative ion tandem mass spectra of three RNase A 
proteolytic peptides that contain the cysteic acid near the C-terminus. The peptide 
88NVACoxK92 fragments to produce primarily y-type fragment ions (y1, y2, y3, y3-17, and 
y4-17) with the negative charge maintained toward the C-terminus (Figure 30a). We 
suspect that the lysine and cysteic acid side chains are interacting with one another to 
prevent v- or w-type side-chain fragment ions. Similarly, the CID spectra of [M – H]- 
ions of 106SITDCoxR111 results in several y-type fragment ions (y2, y3, and y3-17) (Figure 
30b). Note the enhanced ion signal observed for y2 fragment ions, corresponding to 
cleavage between the cysteic acid and aspartic acid residues, similar to fragmentation 
previously reported.126-128 Side-chain loss occurs when the C-terminal amino acid is 
replaced with tyrosine. For example, w3 and w5 fragment ions are observed in the 
negative ion tandem mass spectrum of 93NGQTNCoxY99, corresponding to the side-chain 
losses of asparagine and glutamine, respectively (Figure 30c). Note that these side-chain 
fragment ions occur without the interaction between basic side chains and cysteic acid. 
The v4 ion for the full side chain loss of threonine is also observed at low relative 
abundance at m/z 500.37. Additionally, neither v- nor w-type side-chain cleavage 
fragment ions are observed in the negative ion tandem mass spectrum of native 
93NGQTNCY99 (See Figure 31). Further investigation of peptides with a C-terminal 
cysteic acid is currently underway.  
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Figure 30. Typical negative ion tandem mass spectra for oxidized RNase A proteolytic 
peptides that contain the cysteic acid side chain near the C-terminus of the peptide. (a) 
88NVACoxK92, (b) 106SITDCoxR111, and (c) 93NGQTNCoxY99. Inset figure: expanded 
view of mass range 365-395 m/z illustrating that two fragment ions a4 and w3 are 
present. 
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Figure 31. Negative ion tandem mass spectrum for the native RNase A peptide 
93NGQTNCY99. 
 
Conclusion 
Near complete series of d-type fragment ions were observed in the negative ion 
tandem mass spectra for peptides containing an N-terminal cysteic acid and the side 
chain must require a cleavable β-γ carbon-carbon bond. The cysteic acid at the N-
terminus is suspected to be interacting with the amino acid side chains to promote d-type 
ion formation. As the cysteic acid position moves toward the center of the peptide, d-
type fragment ions are still formed, given that the amino acid side chain C-terminal to 
the cysteic acid contains a cleavable β-γ carbon-carbon bond. When the cysteic acid is 
near the C-terminus of the peptide w-type fragment ions are observed; however, they are 
in low abundance compared to the distinct d-type fragment ion series. 
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CHAPTER VI 
ELUCIDATION OF DISULFIDE-LINKED PEPTIDES VIA CAPILLARY 
ELECTROPHORESIS – MASS SPECTROMETRY 
 
Introduction 
Disulfide bonds are among the most frequent post-translational protein 
modification and their primary function is to maintain and stabilize the native protein 
structure.49-51 Through the proper assignment of disulfide bonds we hope to gain further 
understanding of protein folding and therefore biological function.53, 54, 129 However, 
correctly establishing the native disulfide bond patterns in proteins still remains 
challenging.51, 130 Proteolytic digestion conditions must be carefully pH and temperature 
controlled to prevent undesired disulfide scrambling.51 Disulfide-containing proteins 
cannot undergo thermal denaturation at high temperatures (90˚C) because this results in 
severe disulfide scrambling which gives a false indication of the native disulfide bond 
pattern. Mildly acidic (pH 6) buffer solutions without thermal denaturation can minimize 
the disulfide bond scrambling during the digestion of bovine ribonuclease A.56 Another 
challenge during proteolytic digestion is the inaccessibility of the protease to cleave the 
protein when buried disulfide bonds are not solvent exposed.53, 54 Dual enzyme digestion 
schemes (e.g., trypsin followed by chymotrypsin)56 or alternative proteases  (e.g., pepsin, 
Endoproteinase AspN, Endoproteinase LysC, etc.) could help improve the digestion 
efficiency. 
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 Several mass spectrometry (MS)-based detection schemes have been reported for 
disulfide bond detection/identification including:  tandem MS,57, 58  database search 
algorithms,56, 59-61  chemical reduction,55, 62, 63 chemical oxidation,46, 47, 64 metal ion 
cleavage of disulfide-bonds,65, 66 and recently gas-phase scrambling of disulfide bonds.67 
High-performance liquid chromatography (HPLC) combined with either matrix-assisted 
laser desorption ionization (MALDI) and electrospray ionization (ESI) have been widely 
used for protein identification and disulfide mapping.47, 56, 131 For example, Xu and 
coworkers combine nanospray LC-MS/MS with a database search algorithm to confirm 
disulfide bonds from bovine Ribonuclease A (RNase A) under varied digestion 
conditions.56 However, these fragmentation spectra can be complicated by gas-phase 
disulfide bond cleavage between inter-linked disulfide peptides, which results in a 
limited number of sequence-informative fragment ions from each α and β-chain peptide 
forming the disulfide linkage.57 Schnaible et al. developed a screening method for 
disulfide bonds based on LC pre-fractionation combined with post-source decay of the 
disulfide bond to produce two peptide chains that form the inter-linked disulfide bond.131 
This approach enables disulfide bonds from bovine serum albumin and RNase A to be 
elucidated through working backwards to calculate the intact disulfide-linked peptide 
masses.  
We introduced an on-target performic acid oxidation method that can rapidly 
oxidize disulfide-containing peptides directly on the MALDI sample deposits.48 The 
possibility of disulfide-bond elucidation from a single MALDI deposit was shown for a 
bovine Ribonuclease A proteolytic digest. However, the extreme mass spectral 
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congestion resulting after on-target oxidation makes disulfide bond elucidation difficult 
for complex mixtures. Therefore, pre-fractionation prior to MS would drastically 
decrease the mass spectral complexity after on-target oxidation to allow more 
straightforward disulfide bond elucidation. 
 Capillary electrophoresis (CE) combined with MS has not been extensively used 
for proteomics studies when compared to LC-MS. Nonetheless, several researchers have 
shown that CE-MS is successful towards mapping complex proteomic mixtures.19-24 For 
example, we showed that distinct charge-state trends occur in 2D plots of log (µeff) 
versus log (MW) (measured by MALDI-MS) for standard protein proteolytic digests and 
E. coli derived peptide fractions.19 The charge-state trends directly correlate with the 
number of basic amino acid residues (Arg, Lys, His) present within the peptide, thus 
providing additional information to aid in the confidence of protein identification. For 
example, tryptic peptides along the +3 charge-state trendline have two basic amino acid 
residues and an N-terminal charge. Inter-linked disulfide bridged tryptic peptides would 
exist a high charge states (i.e., +3 or +4 charge state) owing to charge contribution from 
each peptide forming the disulfide linkage. Therefore, these highly charged peptides are 
probable candidates to contain disulfide bonds. This information combined with the 
high-throughput on-target oxidation method will enable CE separations to be 
interrogated for disulfide-linked peptides. Following on-target oxidation, the highly 
probable candidate disulfide-linked peptides will exhibit enhanced negative ion signals 
for oxidized cysteine-containing peptides that are a result of oxidative cleavage of intact 
disulfide-linked peptides. 
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 This report describes an alternative method for disulfide bond elucidation using 
on-target oxidation combined with CE-MS. On-target oxidation provides chemical 
selectivity towards oxidizing disulfide-linked peptides separated by CE to reduce the 
overall mass spectral complexity prior to MS and oxidation. The MALDI sample 
deposits containing enhanced negative ion signals are probable candidate disulfide-
linked peptides. These oxidized cysteine-containing peptides can then be subjected to 
tandem MS for amino acid sequence determination. The utility of this CE-MS disulfide 
elucidation scheme is shown for a bovine Ribonuclease A proteolytic digest.   
 
Experimental 
Chemicals 
Bradykinin (2-9) (PPGFSPFR), adrenocorticotropic hormone (ACTH) (18-39) 
(RPVKVYPNGAEDESAEAFPLEF), bovine ribonuclease A, α-cyano-4-
hydroxycinnamic acid (CHCA), dihydrogen ammonium phosphate (NH4H2PO4), 
ammonium bicarbonate (NH4HCO3), and mass spectrometry grade trypsin were 
purchased from Sigma (St. Louis, MO). HPLC grade methanol (CH3OH), isopropanol, 
and acetone were purchased from EMD Chemicals Inc. (Gibbstown, NJ).  Hydrogen 
peroxide (35% w/w) and formic acid (99% w/w) were purchased from Acros Organics 
(Morris Plains, NJ).  All experiments were performed with 18MΩ water (ddH2O) 
purified using a purification unit from Barnstead International (Dubuque, IA).  All 
chemicals were used as received without further purification.  
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Standard Protein Proteolytic Digestion 
 
 Bovine ribonuclease A (RNaseA) was prepared at 1 mg mL-1 in 2.5 mM histidine 
(pH 7.1). Ribonuclease A was digested using a dual protease scheme similar to described 
previously.48 Briefly, a 100 µL aliquot of the RNaseA stock solution was digested in 2.5 
mM histidine buffer similar to as previously described.132 Trypsin (0.1 µg µL-1) prepared 
in ddH2O was added at a 1:50 enzyme: protein ratio and incubated at 37˚C for 4 hrs. 
Subsequently, chymotrypsin (0.1 µg µL-1) was added at a 1:50 enzyme: protein ratio and 
allowed to digest overnight at 37˚C. Following proteolytic digestion the RNase A digest 
was alkylated with 2-iodoacetamide (IAA) (100 mM prepared in ddH2O) at a final 
concentration of 5 mM IAA and incubated at room temperature for 45 min in the dark. 
 
MALDI Matrix Preparation  
A layer of 5-mg mL-1 CHCA was applied prior to the CE separations using an x-
y-z translation stage (ProBot, LC Packings, Sunnyvale, CA). CHCA was dissolved in 
12:7:1 MeOH:ddH20:IPA with 10-mM dihydrogen ammonium phosphate and doped 
with 50-fmol µL-1 bradykinin fragment 2-9 and 100-fmol µL-1 ACTH fragment 18-39 as 
internal calibrants. Dihydrogen ammonium phosphate was added according to a 
modified matrix preparation procedure by Smirnov and coworkers.89 The CHCA matrix 
solution was infused through a fused-silica capillary at 1.0 µL min-1 with a 5 second 
spotting interval to prepare a 30 row by 30 column array (900 total spots). MALDI 
plates were used for CE fraction collection using the sheath liquid mentioned in the CE-
MALDI section as the overlayer.90 
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CE-MALDI 
CE separations were carried out on a 70-cm (50 µm i.d., 360 µm o.d.) fused-
silica capillary (Polymicro Technologies, Phoenix, AZ) with 200-nm UV detection at 50 
cm on a homebuilt apparatus. The cathodic end capillary tip was interfaced to a ProBot 
(LC Packings, Sunnyvalve, CA) as previously described.19 The CE capillary was coated 
with a neutral linear polyacrylamide dynamic coating (Ultratrol LN, Target Discovery, 
Palo Alto, CA). The background electrolyte consisted of 250-mM FA at pH 2.20. 
Pressurized injections were performed at 2.0 psi for 20 seconds corresponding to a 60 nL 
injection volume.  Separations were performed at a potential of +25 kV, using a 30-kV 
high-voltage power supply (Gamma High-Voltage Research, Ormond Beach, FL). UV 
electropherograms were collected using a homebuilt virtual instrument interface in the 
LabView 7.1 (National Instruments, Austin, TX) environment. CE fractions were 
collected using the ProBot with 10 second spotting intervals.  
 
On-Target Performic Acid Oxidation of CE-MS Separations  
 Performic acid was prepared as previously described.48 Briefly, hydrogen 
peroxide (35% w/w) and formic acid (99% w/w) were mixed at a 1:9 ratio respectively 
and allowed to age at room temperature for 2 hr. The performic acid was stored in a -
20˚C freezer prior to use. On-target performic acid oxidation was performed with a 40 
µL volume of a 1:1 mixture of acetone: performic acid placed directly on the MALDI 
target in a region that does not contain sample. The MALDI target was then placed in a 
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petri dish and incubated at +25˚C for 30 min. Following on-target oxidation the MALDI 
plate was subjected to MALDI analysis without sample cleanup.  
 
MALDI-MS and MALDI-MS/MS 
All MALDI-MS experiments were performed using a 4700 Proteomics Analyzer 
MALDI-TOF/TOF (Applied Biosystems, Framingham, MA). The MALDI-MS data 
were acquired using the reflectron detector in both positive and negative ion modes 
(500-4500 Da, 2100 Da focus mass) using 800 laser shots with internal calibration. 
Positive ion collision-induced dissociation (CID) tandem MS spectra were acquired 
using 10-20% greater laser power than the MS spectra acquisition with atmosphere 
(medium pressure) as the collision gas with 1 kV of collision energy. 
 
Results and Discussion 
 The initial motivation for the on-target oxidation method was to develop 
methodologies to separate complex mixtures of proteolytic peptides and be able to 
readily distinguish disulfide-linked peptides from those that are unmodified proteolytic 
peptides. As illustrated in the negative ion mass spectrum of the Ribonuclease A (RNase 
A) proteolytic digest after on-target oxidation (Figure 12, Chapter III), there are several 
oxidized peptide ion signals that convolute the mass spectrum. Hence, the motivation to 
first pre-fractionate the proteolytic digest via capillary electrophoresis (CE) or liquid 
chromatography (LC) prior to MS analysis. Scheme 7 contains the overall experimental 
design for disulfide elucidation using CE-MS followed by on-target oxidation. First the 
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CE-MS separation would be acquired in positive and negative ion modes to obtain the 
mass spectra before oxidation. Second, the entire CE-MS separation would be subjected 
to on-target oxidation. For this hypothetical example, the inter-linked disulfide bridged 
peptide would be cleaved through oxidative cleavage to convert each α- and β-chain to 
their cysteic acid (SO3H) modified form. These cysteic acid-containing peptides can be 
submitted to tandem MS analysis in either positive or negative ion mode for amino acid 
sequence determination. The disulfide-linked peptide then can be elucidated by back-
calculating the mass of an inter-linked disulfide bridged peptide containing these two α- 
and β-chains. This experimental scheme using CE-MS combined with on-target 
oxidation is demonstrated for a proteolytic digest of bovine RNase A. 
 
 
Scheme 7. Experimental design for disulfide elucidation using CE-MS followed by 
on-target oxidation. 
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RNase A contains four native disulfide bonds, three disulfide bonds are inter-
linked and the remaining disulfide bond is intra-linked.46, 56, 69 Our experimental design 
for CE-MS involves performing proteolytic digestion in neutral conditions (histidine 
buffer, pH 7) to minimize disulfide scrambling combined with 2-iodoacetamide 
alkylation chemistry to protect the free-cysteine residues (i.e., disulfide-linked peptides 
that may become reduced during digestion) from oxidation. The low conductivity of the 
histidine buffer was desired to perform large-volume sample stacking, similar to those 
previously reported.33, 34 The low conductivity of the histidine sample plug causes the 
field strength (V/cm) to drastically increase which causes the positive ions to rapidly 
stack as a narrow band at the sample plug / background electrolyte interface.27, 33 Once 
the positive ions reach the electrophoresis buffer they continue to migrate according to 
their size-to-charge ratio. This sample stacking technique improves the sample injection 
volume ca. 10-fold as opposed to traditional CE injection volumes (i.e., ≤ 1% of the total 
capillary length).25 Figure 32 contains a typical CE-UV electropherogram of the RNase 
A trypsin/chymotrypsin + 2-iodoacetamide proteolytic digest. The leading histidine peak 
occurs around 6.25 min (µobs = 37.3 x 10-5 cm2/V s) followed by the stacked RNase A 
proteolytic peptides and the µeo for this particular run was 8.31 x 10-5 cm2/V s. 
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Figure 32. CE-UV electropherogram of the RNase A proteolytic digest performed in 2.5 
mM histidine buffer. CE conditions: 50/70 cm x 50 µm i.d. UltraTrol LN coated 
capillary; +25 kV potential; 2.0 psi for 20 sec (60 nL) hydrodynamic injection; 
electrolyte: 250 mM formic acid (pH 2.2). 
 
Figure 33 contains a CE-MS plot of log (µeff) versus log (MW) for the RNase A 
trypsin/chymotrypsin digestion mixture. The effective electrophoretic mobility for each 
peptide is calculated by subtracting the µeo from the observed electrophoretic mobility 
(µobs). The peptide molecular weights correspond to the [M + H]+ value observed in the 
MALDI-MS data. Take notice that distinct charge-state trends are observed in these 
data, as we previously reported.19  The basic amino acid residues (Arg, His, and Lys) and 
the N-terminus are protonated under the electrophoretic conditions (pH 2.2) of the 
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experiment. The highly-charged peptides either contain missed cleavages from the 
trypsin digestion or they could be disulfide-linked peptides. For example, a disulfide-
linked peptide with an inter-linked disulfide bond would be +3 or +4 depending on the 
number of basic amino acid residues within each peptide chain forming the disulfide 
bridge. Therefore, the peptides along these high charge state trends are probable 
candidates to contain disulfide bonds. The charge state information is very helpful to 
narrow down the number of candidate disulfide-linked peptides from a complex mixture. 
The on-target oxidation method applied to the entire CE-MS separation should provide 
chemical selectivity to drastically decrease the number of candidates. The performic acid 
oxidation selectively cleaves the disulfide bond to create two new peptides each 
containing a cysteic acid which results in a 48 Da mass shift and enhanced negative ion 
formation.  The candidate disulfide-linked peptides that have enhanced negative ion 
signals present in the negative ion mass spectra are denoted in Figure 33 with open 
diamonds (◊). Two peptides are alphabetically labeled to later illustrate the typical 
negative ion mass spectra before and after on-target oxidation. 
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Figure 33. CE-MS plot of log (µeff) versus log (MW) for the RNase A 
trypsin/chymotrypsin digest + 2-iodoacetamide. The black diamonds (♦) represent 
proteolytic peptides derived from RNase A and the open diamonds (◊) represent 
candidate disulfide-linked peptides. 
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Figure 34 contains typical negative ion mass spectra (a) before and (b) after on-
target oxidation of a single CE-MS fraction at 13.67 min (denoted as A in Figure 33). 
The negative ion mass spectrum prior to oxidation contains a single ion signal at m/z 
1533.63 (S/N 159) and the internal calibrants bradykinin (2-9) and ACTH (18-39). 
Following on-target oxidation, the abundance of the m/z 1533.63 ion signal drastically 
decreases (S/N 23) which indicates this peptide has undergone oxidative cleavage to 
produce to new oxidized peptides. These oxidized peptides correspond to 
118YPNCoxAY123 (m/z 776.26, S/N 784) and 66CoxKPVNTF72 (m/z 854.38, S/N 644) 
from RNase A. Note the enhanced negative ion signal of these two oxidized peptides 
compared to the abundance of the intact disulfide-linked peptide ion signal at m/z 
1533.63. The increased acidity of the cysteic acid group drastically improves the 
ionization efficiency of the negative ions. Adding together the non-oxidized peptide 
masses and accounting for an inter-linked disulfide bond results in a [M – H]-calc = 
1533.65 Da which corresponds to a native disulfide linkage between Cys66 and Cys121 
(118YPNCAY123 / 66CKPVNTF72). The CE separation prior to MS analysis simplifies the 
mass spectrum before on-target oxidation to enable straightforward disulfide bond 
elucidation when compared to the on-target oxidation of the entire RNase A proteolytic 
digest. 
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Figure 34. Typical negative ion mass spectra of a single CE-MS fraction (13.67 min) 
acquired (a) before and (b) after on-target oxidation. The candidate disulfide-linked 
peptide corresponds to 66CKPVNTF72 / 118YPNCAY123 ([M-H]-calc = 1533.65 Da). 
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Figure 35. Typical negative ion mass spectra of a single CE-MS fraction (11.00 min) 
acquired (a) before and (b) after on-target oxidation. The candidate disulfide-linked 
peptide corresponds to 52CNQMMK57 / 106SITDCR111 ([M-H]-calc = 1443.58 Da). 
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Figure 35 contains the negative ion mass spectra (a) before and (b) after on-target 
oxidation of a candidate disulfide-linked peptide with a migration time of 11.00 min 
(denoted as B in Figure 33). Note the low abundance of the [M – H]- ion (m/z 1443.53) 
and oxidized methionine forms of this peptide [M – H + O]- and [M – H + O2]- at  m/z 
1459.53 and m/z 1475.54, respectively. These methionine residues become oxidized 
either in-solution during proteolytic digestion or when exposed to ambient air on the 
MALDI target. After on-target oxidation, these ion signals diminish to form two new 
oxidized peptides 106SITDCoxR111 (m/z 740.28, S/N 798) and 52CoxNQMMK57 (m/z 
864.25, S/N 526). As we have previously shown, the methionine side chains also 
become fully oxidized, i.e., incorporating two oxygen atoms per methionine residue 
(denoted in bold italics).48 Despite having several oxidized forms of the intact disulfide-
linked peptide present, there are only two predominant products produced from on-target 
oxidation. Therefore, we are able to elucidate these peptides as the native disulfide 
linkage between Cys52 and Cys110 (52CNQMMK57 / 106SITDCR111) with several oxidized 
methionine variations present. 
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In our previous work with on-target oxidation of RNase A proteolytic peptides 
we evaluated the effect of the cysteic acid position on the negative ion fragmentation of 
cysteic acid-containing peptides (See Chapter V). In brief, we showed that side chain 
loss fragment ions readily occur for peptides that contain an N-terminal cysteic acid. 
Similar fragment ion types are observed (b- and y-type fragment ions) in the negative ion 
fragmentation spectra and the peptide can be successfully sequenced; however, these 
side chain loss fragment ions make these fragmentation spectra not as widely accepted as 
the positive ion peptide fragmentation nomenclature.122, 123  Therefore, for the CE-MS 
combined with on-target oxidation workflow we have decided to acquire the positive ion 
fragmentation spectra owing to the ease of interpretation. Figure 36 contains 
representative positive ion fragmentation spectra for (a) 52CoxNQMMK57 and (b) 
106SITDCoxR111. These oxidized peptides were fragmented from the CE-MALDI sample 
deposit at 11.00 min. Distinct y-type fragment ion series are present for both oxidized 
peptides which enables rather straightforward peptide amino acid sequencing. 
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Figure 36. Positive ion fragmentation spectra of the oxidized versions of (a) 
52CoxNQMMK57 and (b) 106SITDCoxR111 acquired from a single oxidized CE-MS fraction 
at 11.00 min. 
 
  
Table 4 contains a summary of the confirmed cysteic acid-containing peptides 
detected in the negative ion mode throughout the entire RNase A proteolytic digest CE-
MS separation. Note that some of the oxidized peptides are repeated because they are 
involved in disulfide bridging in another disulfide-linked peptides formed from a 
different proteolytic cleavage site. For example, the RNase A oxidized peptide 
106SITDCoxR111 (m/z 740.27) is observed at a migration time of 11.00 and 13.17 min. 
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This peptide is involved in two disulfide-linked peptides: 52CNQMMK57 / 106SITDCR111 
([M + H]+obs = 1445.59 Da) and 52CNQMM56 / 106SITDCR111 ([M + H]+obs = 1317.49 Da) 
both corresponding to the native disulfide bridge from Cys52 – Cys110. The disulfide-
linked peptide at m/z 1317.49 has a longer migration time 13.17 min (µeff = 18.0 x 10-5 
cm2/V s) owing to the decrease in charge state from a +4 to +3 peptide. This list of 
oxidized RNase A proteolytic peptides can also be used to generate a list of candidate 
inter-linked disulfide bridged peptides, similar to the table presented in Figure 11b in 
Chapter III. From this list of candidate disulfide-linked peptides the calculated masses 
can be matched from those [M + H]+ ions observed in the positive ion CE-MS data. 
Twelve native disulfide-linked peptides accounting for each disulfide bond in RNase A 
are summarized in Table 5. One major limitation of the CE-MS combined with on-target 
oxidation is illustrated by the disulfide-linked peptide at m/z 1161.49 (121CAY123 / 
66CKPVNTF72) which would result in an oxidized peptide below the typical mass range 
of interest for MALDI because of matrix clusters below m/z 500. Therefore, this 
assignment is uncertain because the oxidized peptide 121CoxAY123 ([M – H + O3]-calc = 
402.09 Da) was not detected in the negative ion mass spectrum. Overall, the pre-
fractionation step with CE provides simplified mass spectra prior to on-target oxidation 
to enable disulfide bond elucidation from the model protein RNase A.  
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Table 4. Summary of Oxidized RNase A Proteolytic Peptides Identified from the 
On-Target Oxidation of an Entire CE-MS Separation 
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Table 5. Summary of CE-MS Confirmed RNase A Disulfide-Linked Peptides  
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Conclusion 
The on-target oxidation method was combined with CE-MS to successfully 
elucidate disulfide bonds from a bovine RNase A proteolytic digest. The mass spectral 
complexity of the CE-MS fractions was decreased when compared to an entire 
proteolytic digestion mixture to enable simplified disulfide elucidation. A total of twelve 
RNase A disulfide-linked peptides accounting for all four native disulfide bonds were 
detected using this CE-MS detection scheme. The oxidized cysteine-containing peptides 
were subjected to positive ion tandem MS analysis owing to the ease of interpretation. 
The low conductivity of histidine buffer digestion directly enables sample stacking 
injections to improve the CE sample loading capacity. In the future we plan to combine 
this on-target oxidation methodology with LC-MALDI-MS to locate disulfide-linked 
peptides within more complex proteomic mixtures. 
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CHAPTER VII 
CONCLUSIONS 
 
Summary 
 An alternative method for disulfide bond elucidation using CE-MS combined 
with an on-target performic acid oxidation method was developed. The charge state 
information (i.e., number of basic amino acid residues) provided in the 2D CE-MS plots 
has proven useful to enhance the confidence of peptide/protein identifications in the case 
of limited tandem MS data. The CE-MS charge-state trends also assist in the detection of 
post-translationally modified peptides. Specifically, α-casein derived proteolytic 
peptides containing a phosphorylation are observed in a lower charge state trendline, 
which greatly simplifies phosphopeptide detection and enables screening.  
The information provided in the charge-state trends have also been applied to 
disulfide-linked peptide screening using CE-MS. The highly charged interlinked 
disulfide-containing peptides should be located along the +3, +4, or greater charge state 
trends, thus creating a candidate list of disulfide-linked peptides. However, the 
intralinked disulfide-containing peptides will not necessarily be highly charged peptides. 
Therefore, an on-target performic acid oxidation method was developed to provide 
chemical selectivity towards locating disulfide-containing peptides. The on-target 
oxidation method provides significant advantages over traditional solution-phase 
oxidation methods because of the decreased sample handling and reaction time. The on-
target oxidation method can easily be adapted to simultaneously oxidize ca. 900 MALDI 
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sample deposits in 15 minutes. From the on-target oxidation of an entire CE-MS 
separation, the candidate list of disulfide-linked peptides can be further narrowed down 
based on observing enhanced negative ion signals after oxidation. After confirming these 
cysteic-containing peptides via tandem MS the disulfide-linked peptides can be 
elucidated. Interestingly, the negative ions of these cysteic acid-containing peptides 
fragment to produce side chain loss fragment ions (d-type fragment ions) when the 
cysteic acid is at the N-terminus. This on-target oxidation combined with CE-MS 
experimental scheme was applied to a proteolytic digest of bovine RNase A. Twelve 
RNase A disulfide-linked peptides accounting for all four native disulfide bonds were 
elucidated using this CE-MS detection scheme. 
 The experimental variables (e.g., oxidation temperature, performic acid vapor 
exposure time, and MALDI matrix) associated with the on-target oxidation method were 
extensively evaluated to improve the oxidized peptide ion yield. Overall, the elevated 
temperature oxidation (+25˚C) does not have a detrimental effect on peptides that 
contain histidine, tryptophan, or tyrosine amino acid residues when CHCA is used 
during oxidation. Intact insulin can be successfully oxidized to form oxidized insulin α- 
and β-chains when 2,4-dihydroxyacetophenone (2,4-DHAP) is used during oxidation. 
The alternative matrix (crystal lattice) improves the accessibility of the performic acid 
vapor to oxidize insulin within the crystal lattice. Improved oxidized product yield was 
also observed for oxidized Cys-kemptide (CoxLRRASLG) when using 2,4-DHAP or 3,5-
dimethyl-4-hydroxycinnamic acid as the MALDI matrix during oxidation. In addition, 
the on-target oxidation was adapted towards oxidizing intact proteins followed by on-
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target proteolytic digestion, both performed in the presence of the MALDI matrix. For 
example, the disulfide bonds of bovine pancreatic trypsin inhibitor were cleaved via 
oxidative cleavage to expose the trypsin cleavage sites which results in improved 
proteolytic digestion. On-target oxidation of intact proteins followed by on-target 
proteolytic digestion could easily be adapted to imaging mass spectrometry to improve 
the digestion efficiency of highly disulfide-linked proteins found within tissue sections. 
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www.interscience.wiley.com. The Materials shall not be used in any other manner or for 
any other purpose. Permission is granted subject to an appropriate acknowledgement 
given to the author, title of the material/book/journal and the publisher and on the 
understanding that nowhere in the text is a previously published source acknowledged 
for all or part of this Material. Any third party material is expressly excluded from this 
permission.  
 
3. With respect to the Materials, all rights are reserved. No part of the Materials may be 
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copied, modified, adapted, translated, reproduced, transferred or distributed, in any form 
or by any means, and no derivative works may be made based on the Materials without 
the prior permission of the respective copyright owner. You may not alter, remove or 
suppress in any manner any copyright, trademark or other notices displayed by the 
Materials. You may not license, rent, sell, loan, lease, pledge, offer as security, transfer 
or assign the Materials, or any of the rights granted to you hereunder to any other person.  
 
4. The Materials and all of the intellectual property rights therein shall at all times 
remain the exclusive property of John Wiley & Sons Inc or one of its related companies 
(WILEY) or their respective licensors, and your interest therein is only that of having 
possession of and the right to reproduce the Materials pursuant to Section 2 herein 
during the continuance of this Agreement. You agree that you own no right, title or 
interest in or to the Materials or any of the intellectual property rights therein. You shall 
have no rights hereunder other than the license as provided for above in Section 2. No 
right, license or interest to any trademark, trade name, service mark or other branding 
("Marks") of WILEY or its licensors is granted hereunder, and you agree that you shall 
not assert any such right, license or interest with respect thereto.  
 
5. WILEY DOES NOT MAKE ANY WARRANTY OR REPRESENTATION OF ANY 
KIND TO YOU OR ANY THIRD PARTY, EXPRESS, IMPLIED OR STATUTORY, 
WITH RESPECT TO THE MATERIALS OR THE ACCURACY OF ANY 
INFORMATION CONTAINED IN THE MATERIALS, INCLUDING, WITHOUT 
LIMITATION, ANY IMPLIED WARRANTY OF MERCHANTABILITY, 
ACCURACY, SATISFACTORY QUALITY, FITNESS FOR A PARTICULAR 
PURPOSE, USABILITY, INTEGRATION OR NON-INFRINGEMENT AND ALL 
SUCH WARRANTIES ARE HEREBY EXCLUDED BY WILEY AND WAIVED BY 
YOU.  
 
6. WILEY shall have the right to terminate this Agreement immediately upon breach of 
this Agreement by you.  
 
7. You shall indemnify, defend and hold harmless WILEY, its directors, officers, agents 
and employees, from and against any actual or threatened claims, demands, causes of 
action or proceedings arising from any breach of this Agreement by you.  
 
8. IN NO EVENT SHALL WILEY BE LIABLE TO YOU OR ANY OTHER PARTY 
OR ANY OTHER PERSON OR ENTITY FOR ANY SPECIAL, CONSEQUENTIAL, 
INCIDENTAL, INDIRECT, EXEMPLARY OR PUNITIVE DAMAGES, HOWEVER 
CAUSED, ARISING OUT OF OR IN CONNECTION WITH THE DOWNLOADING, 
PROVISIONING, VIEWING OR USE OF THE MATERIALS REGARDLESS OF 
THE FORM OF ACTION, WHETHER FOR BREACH OF CONTRACT, BREACH 
OF WARRANTY, TORT, NEGLIGENCE, INFRINGEMENT OR OTHERWISE 
(INCLUDING, WITHOUT LIMITATION, DAMAGES BASED ON LOSS OF 
PROFITS, DATA, FILES, USE, BUSINESS OPPORTUNITY OR CLAIMS OF 
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THIRD PARTIES), AND WHETHER OR NOT THE PARTY HAS BEEN ADVISED 
OF THE POSSIBILITY OF SUCH DAMAGES. THIS LIMITATION SHALL APPLY 
NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY 
LIMITED REMEDY PROVIDED HEREIN.  
 
9. Should any provision of this Agreement be held by a court of competent jurisdiction 
to be illegal, invalid, or unenforceable, that provision shall be deemed amended to 
achieve as nearly as possible the same economic effect as the original provision, and the 
legality, validity and enforceability of the remaining provisions of this Agreement shall 
not be affected or impaired thereby.  
 
10. The failure of either party to enforce any term or condition of this Agreement shall 
not constitute a waiver of either party's right to enforce each and every term and 
condition of this Agreement. No breach under this agreement shall be deemed waived or 
excused by either party unless such waiver or consent is in writing signed by the party 
granting such waiver or consent. The waiver by or consent of a party to a breach of any 
provision of this Agreement shall not operate or be construed as a waiver of or consent 
to any other or subsequent breach by such other party.  
 
11. This Agreement may not be assigned (including by operation of law or otherwise) by 
you without WILEY's prior written consent.  
 
12. These terms and conditions together with CCC’s Billing and Payment terms and 
conditions (which are incorporated herein) form the entire agreement between you and 
WILEY concerning this licensing transaction and (in the absence of fraud) supersedes all 
prior agreements and representations of the parties, oral or written. This Agreement may 
not be amended except in a writing signed by both parties. This Agreement shall be 
binding upon and inure to the benefit of the parties' successors, legal representatives, and 
authorized assigns.  
 
13. In the event of any conflict between your obligations established by these terms and 
conditions and those established by CCC’s Billing and Payment terms and conditions, 
these terms and conditions shall prevail.  
 
14. WILEY expressly reserves all rights not specifically granted in the combination of 
(i) the license details provided by you and accepted in the course of this licensing 
transaction, (ii) these terms and conditions and (iii) CCC’s Billing and Payment terms 
and conditions.  
 
15. This Agreement shall be governed by and construed in accordance with the laws of 
England and you agree to submit to the exclusive jurisdiction of the English courts.  
 
BY CLICKING ON THE "I ACCEPT" BUTTON, YOU ACKNOWLEDGE THAT 
YOU HAVE READ AND FULLY UNDERSTAND EACH OF THE SECTIONS OF 
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AND PROVISIONS SET FORTH IN THIS AGREEMENT AND THAT YOU ARE IN 
AGREEMENT WITH AND ARE WILLING TO ACCEPT ALL OF YOUR 
OBLIGATIONS AS SET FORTH IN THIS AGREEMENT.  
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